<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Oxid Med Cell Longev</journal-id><journal-id journal-id-type="iso-abbrev">Oxid Med Cell Longev</journal-id><journal-id journal-id-type="publisher-id">OMCL</journal-id><journal-title-group><journal-title>Oxidative Medicine and Cellular Longevity</journal-title></journal-title-group><issn pub-type="ppub">1942-0900</issn><issn pub-type="epub">1942-0994</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6323437</article-id><article-id pub-id-type="doi">10.1155/2018/6468593</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Essential Oils and Their Major Compounds in the Treatment of Chronic Inflammation: A Review of Antioxidant Potential in Preclinical Studies and Molecular Mechanisms</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>de Lavor</surname><given-names>&#x000c9;rica Martins</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Fernandes</surname><given-names>Ant&#x000f4;nio Wilton Cavalcante</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>de Andrade Teles</surname><given-names>Roxana Braga</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Leal</surname><given-names>Ana Edil&#x000e9;ia Barbosa Pereira</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9458-1744</contrib-id><name><surname>de Oliveira J&#x000fa;nior</surname><given-names>Raimundo Gon&#x000e7;alves</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gama e Silva</surname><given-names>Mariana</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>de Oliveira</surname><given-names>Ana Paula</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Silva</surname><given-names>Juliane Cabral</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>de Moura Fontes Ara&#x000fa;jo</surname><given-names>Maria Tais</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-6634-4207</contrib-id><name><surname>Coutinho</surname><given-names>Henrique Douglas Melo</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-1065-9581</contrib-id><name><surname>de Menezes</surname><given-names>Irwin Rose Alencar</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Picot</surname><given-names>Laurent</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0867-1357</contrib-id><name><surname>da Silva Almeida</surname><given-names>Jackson Roberto Guedes</given-names></name><email>jackson.guedes@univasf.edu.br</email><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>Center for Studies and Research of Medicinal Plants, Federal University of San Francisco Valley, 56304-205 Petrolina, Pernambuco, Brazil</aff><aff id="I2">
<sup>2</sup>UMRi CNRS 7266 LIENSs, University of La Rochelle, La Rochelle, France</aff><aff id="I3">
<sup>3</sup>Department of Biological Chemistry, Regional University of Cariri, 63105-000 Crato, Cear&#x000e1;, Brazil</aff><author-notes><fn fn-type="other"><p>Academic Editor: Demetrios Kouretas</p></fn></author-notes><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>23</day><month>12</month><year>2018</year></pub-date><volume>2018</volume><elocation-id>6468593</elocation-id><history><date date-type="received"><day>28</day><month>6</month><year>2018</year></date><date date-type="accepted"><day>1</day><month>11</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 &#x000c9;rica Martins de Lavor et al.</copyright-statement><copyright-year>2018</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Inflammatory diseases result from the body's response to tissue damage, and if the resolution is not adequate or the stimulus persists, there will be progression from acute inflammation to chronic inflammation, leading to the development of cancer and neurodegenerative and autoimmune diseases. Due to the complexity of events that occur in inflammation associated with the adverse effects of drugs used in clinical practice, it is necessary to search for new biologically active compounds with anti-inflammatory activity. Among natural products, essential oils (EOs) present promising results in preclinical studies, with action in the main mechanisms involved in the pathology of inflammation. The present systematic review summarizes the pharmacological effects of EOs and their compounds in <italic>in vitro</italic> and <italic>in vivo</italic> models for inflammation. The research was conducted in the following databases: PubMed, Scopus, BIREME, Scielo, Open Grey, and Science Direct. Based on the inclusion criteria, 30 articles were selected and discussed in this review. The studies listed revealed a potential activity of EOs and their compounds for the treatment of inflammatory diseases, especially in chronic inflammatory conditions, with the main mechanism involving reduction of reactive oxygen and nitrogen species associated with an elevation of antioxidant enzymes as well as the reduction of the nuclear factor kappa B (NF-<italic>&#x003ba;</italic>B), reducing the expression of proinflammatory cytokines. Thus, this review suggests that EOs and their major compounds are promising tools for the treatment of chronic inflammation.</p></abstract><funding-group><award-group><funding-source>State University of Feira de Santana</funding-source></award-group><award-group><funding-source>Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Ci&#x000ea;ncia e Tecnologia do Estado de Pernambuco</funding-source></award-group><award-group><funding-source>Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior</funding-source></award-group><award-group><funding-source>Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico</funding-source></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Inflammation is characterized as a normal response to tissue damage caused by several potentially injurious stimuli, induced by biological, chemical, and physical factors [<xref rid="B1" ref-type="bibr">1</xref>]. Initially, inflammatory agents elicit an acute inflammatory response which generally promotes complete destruction of the irritants. This type of inflammation persists for a short time and is beneficial for the host [<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>]. However, if resolution of inflammation is inadequate or the stimulus persists, chronic inflammation occurs, predisposing the host to various diseases including, for example, cancer and neurodegenerative diseases [<xref rid="B4" ref-type="bibr">4</xref>&#x02013;<xref rid="B6" ref-type="bibr">6</xref>].</p><p>During chronic inflammation, a variety of intracellular signaling pathways are activated, comprising of cell surface receptors, tyrosine kinases, and transcription factors, leading to overexpression of proinflammatory genes involved in the development of chronic diseases [<xref rid="B2" ref-type="bibr">2</xref>]. Furthermore, the cellular components represented by the mast cells and leukocytes are recruited to the site of the damage, which leads to a &#x0201c;respiratory burst&#x0201d; result of increased oxygen uptake and therefore an increased release and accumulation of reactive oxygen species (ROS) and reactive nitrogen species (RNS) at the site of damage [<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B4" ref-type="bibr">4</xref>&#x02013;<xref rid="B7" ref-type="bibr">7</xref>]. Under physiological conditions, ROS are generated in phagocytes to neutralise the invading organisms, presenting an important role in the host defense mechanism. In contrast to oxidant mechanisms, the organism has endogenous defense antioxidant systems, including for example superoxide dismutase, glutathione peroxidase, and catalase. When ROS production is greater than cellular antioxidant capacity, oxidative stress can damage DNA, proteins, and lipids [<xref rid="B8" ref-type="bibr">8</xref>&#x02013;<xref rid="B11" ref-type="bibr">11</xref>].</p><p>A diversity of protein kinases is activated in the inflammatory process, such as members of the Janus-activated kinase (JAK), phosphatidylinositol-3-kinase (PI3K/, AKT), and mitogen-activated protein kinase (MAPK) families to alter cell proliferation. In the chronic inflammatory process, the excessive activation of these signaling pathways causes also the activation of certain transcription factors, such as NF-<italic>&#x003ba;</italic>B, signal transducer and activator of transcription 3 (STAT3), hypoxia-inducible factor-1<italic>&#x003b1;</italic> (HIF1-<italic>&#x003b1;</italic>), and activator protein-1 (AP-1), potentiating the initial inflammatory response. In addition to these factors, the cyclooxygenase enzyme (COX), inducible nitric oxide synthase (iNOS), cytokines, and chemokines have also been reported to play a role in oxidative stress-induced inflammation [<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>].</p><p>In recent years, the search for more effective drugs for the treatment of the inflammation with fewer side effects has encouraged researchers to study and develop new drugs. The search for natural products derived from plants is a promising reality, and among the substances with pharmacological potential we can cite the essential oils (EOs).</p><p>EOs are liquid mixtures of volatile compounds obtained from aromatic plants, which represent a small fraction of the plant composition [<xref rid="B14" ref-type="bibr">14</xref>]. However, they are responsible for providing characteristics that favor their use in the food, cosmetic, and pharmaceutical applications. Essential oils have a complex composition; the great majority of the identified components include terpenes (oxygenated or not), predominantly monoterpenes and sesquiterpenes. However, allyl and propenylphenols (phenylpropanoids) also are important components of some essential oils [<xref rid="B15" ref-type="bibr">15</xref>&#x02013;<xref rid="B17" ref-type="bibr">17</xref>]. These secondary metabolites have been related as potent antioxidants, free radical scavengers, and metal chelators, also presenting antinociceptive, neuroprotective, anticonvulsant, and anti-inflammatory properties, reported in preclinical studies, characterizing as potential source for the development of new drugs [<xref rid="B17" ref-type="bibr">17</xref>&#x02013;<xref rid="B20" ref-type="bibr">20</xref>].</p><p>The objective of this review was to relate the use of essential oils correlating its antioxidant effect in the treatment of chronic inflammations.</p></sec><sec id="sec2"><title>2. Material and Methods</title><sec id="sec2.1"><title>2.1. Search Strategy</title><p>In this review, the specialized databases PubMed, Science Direct, Scopus, Open Grey, Scielo, and BIREME were used for literature search in March and April 2018, using different combinations of the following keywords: essential oils, volatile oils, antioxidants, and inflammation. We did not contact investigators, and we have not attempted to identify unpublished data until the date of the search.</p></sec><sec id="sec2.2"><title>2.2. Study Selection</title><p>In this step, two independent researchers (J.C.S. and A.W.C.F.) first selected the articles according to title and abstract and finally through an analysis of the full-text publication. The following inclusion criteria were applied: studies with EOs or their major compounds with anti-inflammatory and antioxidant activity <italic>in vitro</italic> and/or <italic>in vivo</italic>. Studies were excluded according to the following exclusion criteria: review articles, meta-analyses, abstracts, conference proceedings, editorials/letters, case reports and studies in humans, and articles published over 20 years ago. Additional papers were included in our study after analyses of all references from the selected articles. In cases of nonconsensus, a third independent review was consulted (E.M.L.) for final decision.</p></sec><sec id="sec2.3"><title>2.3. Data Extraction</title><p>Data were collected and examined by one reviewer using standardized forms and were checked by a second reviewer. The information extracted from the articles included EOs or their major compounds, cell lines (<italic>in vitro</italic> studies), animal models (<italic>in vivo</italic> studies), doses or concentrations, routes of administration, biochemical assays, and molecular mechanisms investigated.</p></sec><sec id="sec2.4"><title>2.4. Methodological Quality Assessment</title><p>The risk of bias and quality of preclinical <italic>in vivo</italic> studies were performed using an adapted checklist [<xref rid="B21" ref-type="bibr">21</xref>&#x02013;<xref rid="B23" ref-type="bibr">23</xref>]. This investigation allowed assessing the methodological quality of the included studies concerning mainly the randomization of the treatment allocation, blinded drug administration, blinded outcome assessment, and outcome measurements.</p></sec></sec><sec id="sec3"><title>3. Results and Discussion</title><sec id="sec3.1"><title>3.1. Study Selection</title><p>The primary search identified 429 articles (200 from Scopus, 18 from Science Direct, 32 from BIREME, and 179 from PubMed). However, 146 manuscripts were indexed in two or more databases and considered only once, resulting in 283 original articles. After an initial screening of titles and abstracts, 192 articles were excluded because they did not meet the inclusion criteria or presented completely different themes from the proposal of this review. After an initial screening of titles and abstracts and a full-text analysis, 27 articles were considered potentially relevant. In addition, 3 articles were included after manual search for data extraction, totalizing 30 final articles included in this systematic review. A flowchart illustrating the progressive study selection and numbers at each stage is shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p></sec><sec id="sec3.2"><title>3.2. Characteristics of Included Studies</title><p>The selected final articles were carefully analyzed in relation to the country where the study was conducted, year of publication, family of the studied species, and whether the study was carried out with essential oils or substances obtained from them. <xref rid="tab1" ref-type="table"> Table 1</xref> summarizes general information contained in the selected <italic>in vitro</italic> and <italic>in vivo</italic> studies.</p><p>Studies were conducted by research groups located in about 13 different countries. Most of the investigations were authored by researchers from Brazil (7 reports, 24.13%), China (6 reports, 20.68%), and India (5 reports, 17.24%).</p><p>The largest number of studies found in Brazil is justified by the fact that Brazil has an extremely rich biodiversity, corresponding to approximately 20% of all living species known globally, comprising over 45,000 species of higher plants. In addition, the Brazilian population has a historical tradition in the use of medicinal plants for the treatment of different diseases, including acute and/or chronic inflammation disorders [<xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B55" ref-type="bibr">55</xref>]. Another interesting fact is the number of studies conducted in China and India, which may be justified as a reflection of the contribution of Oriental medicine in the search and development for new drugs from natural products. In fact, traditional Chinese medicine (TCM) and Ayurveda as major traditional treatment systems used not only in India and China but also in several countries contributed to the development of new pharmaceutical products based on plant species [<xref rid="B56" ref-type="bibr">56</xref>&#x02013;<xref rid="B58" ref-type="bibr">58</xref>].</p><p>Regarding the number of annual publications, we noted that a large number of articles were published from 2010 to 2015 (12 reports). Only in the last three years were 18 studies (62.02%) found, suggesting that the involvement of oxidative stress in anti-inflammatory activity of essential oils or their major compounds has attracted the attention of the researchers in diverse regions of the world. These results are graphically presented in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</p><p>Among the included articles, only 10 (32.25%) corresponded to studies with isolated components of essential oils, demonstrating that reports involving EOs are still predominant in this subject. Of these oils, three studies were reported for species belonging to the Rutaceae family and two studies for the families Zingiberaceae, Apiaceae, Cupressaceae, and Lamiaceae. The other studies correspond to other families reported in <xref rid="tab1" ref-type="table">Table 1</xref>.</p><p>As described in <xref rid="tab1" ref-type="table">Table 1</xref>, our review included 2 reports presenting in <italic>vitro</italic> and <italic>in vivo</italic> studies, 9 reports presenting only <italic>in vitro</italic> studies, and 19 reports presenting only <italic>in vivo</italic> studies. In the studies reported in this review, biochemical and molecular targets were verified by colorimetric and enzymatic assays, biochemical analyses, and techniques such as Western blot and immunohistochemistry. These studies base their assays on methodologies using cell culture commonly found in chronic inflammatory processes, such as macrophages, monocytes, astrocytes, and cancer cells, correlating anti-inflammatory results with the antioxidant potential of essential oil or their major components. The evaluated <italic>in vitro</italic> studies parameters and main outcomes are summarized in <xref rid="tab2" ref-type="table">Table 2</xref> and <italic>in vivo</italic> studies in <xref rid="tab3" ref-type="table">Table 3</xref>.</p></sec><sec id="sec3.3"><title>3.3. Methodological Quality of In Vivo Studies</title><p>Regarding methodological quality, all <italic>in vivo</italic> studies were evaluated using a standardized checklist, as shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>. It was observed that all studies described the objectives, outcomes to be measured, and main findings obtained. However, none of the included articles reported sample size calculation. In general, doses, routes of administration, and frequency of treatment were adequately described. Most of the <italic>in vivo</italic> studies (18 reports, 85.7%) adequately reported the animal allocation, but less than half (10 reports, 47.6%) reported that the animals were randomly housed. In addition, the majority of included studies did not make it clear if the investigators or the outcome assessor were blinded from the treatment used.</p><p>The number of animals to be used, randomization, and blinding are important steps in preclinical protocols in order to reduce the risk of bias and improve translatability of animal research [<xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B60" ref-type="bibr">60</xref>]. In this way, the evaluation of the methodological quality indicated that the majority of <italic>in vivo</italic> studies included in this review present moderate quality, which limits the interpretation of the results.</p></sec><sec id="sec3.4"><title>3.4. In Vitro Tests of Anti-inflammatory Activity</title><p>Researchers, when proposing to investigate the pharmacological evaluation of substances, initially carry out <italic>in vitro</italic> tests, since these tests present a high reproducibility and function as a trait to evaluate the pharmacological potential of these substances, as for example the anti-inflammatory activity. The assays employed are, in most instances, cell culture techniques, in which the cells receive various stimuli (chemical or biological) that induce the production of mediators involved in inflammatory processes, such as arachidonic acid and cytokines and their metabolites [<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B42" ref-type="bibr">42</xref>].</p><p>In the majority of <italic>in vitro</italic> selected papers, the anti-inflammatory activity tests employed the macrophage cell line RAW 264.7 activated by LPS [<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B48" ref-type="bibr">48</xref>]. Macrophages play a critical role in the inflammatory process through the production of various cytokines. When these cells are activated, they express the inflammatory enzymes (iNOS and COX-2) and proinflammatory cytokines (TNF-<italic>&#x003b1;</italic> and IL-6). However, they also may play an anti-inflammatory role in which they express IL-4, IL-13, or IL-10 cytokines [<xref rid="B61" ref-type="bibr">61</xref>&#x02013;<xref rid="B63" ref-type="bibr">63</xref>].</p><p>Other cells participate in the inflammatory process and have a crucial role in the development of inflammatory diseases. To evaluate this activity, Singh et al. [<xref rid="B64" ref-type="bibr">64</xref>] proposed the utilization of the human THP-1 cell, a common model to estimate modulation of monocyte and macrophage activities. Circulating monocytes have the potential to differentiate into tissue macrophages, providing help in the phagocytosis of invading pathogens, reducing tissue aggression by potentially harmful agents [<xref rid="B65" ref-type="bibr">65</xref>].</p><p>In recent years, inflammatory processes have been correlated to the development of chronic diseases. However, chronic inflammation and cytokine dysfunction are associated with conditions such as cancer progression, cardiovascular disease, diabetes, and neurodegenerative disease [<xref rid="B66" ref-type="bibr">66</xref>]. To better study these molecular aspects, inflammatory models using microglial [<xref rid="B29" ref-type="bibr">29</xref>] and astrocyte [<xref rid="B43" ref-type="bibr">43</xref>] cell lines have been used to evaluate the influence of inflammatory processes on the development of neurodegenerative diseases and tumor cell lines such as HepG2 [<xref rid="B27" ref-type="bibr">27</xref>] to evaluate the relationship between the processes inflammatory and malignant neoplasms.</p></sec><sec id="sec3.5"><title>3.5. Animal Models in Chronic Inflammation</title><p>Chronic inflammation is an aggravating factor for tissue damage, commonly present in many chronic diseases, including asthma, obstructive pulmonary disease, and neuroinflammatory and autoimmune disorders [<xref rid="B67" ref-type="bibr">67</xref>]. For this reason, it is necessary to understand the molecular mechanisms involved in the inflammatory process in order to develop new treatment and prevention protocols. Thus, many experimental models have been developed, most often using mice and rats, in order to correlate the pathophysiology of the disease and to aid in the development of new drugs [<xref rid="B68" ref-type="bibr">68</xref>, <xref rid="B69" ref-type="bibr">69</xref>].</p><p>Concerning <italic>in vivo</italic> studies included in this review, EOs were investigated in experimental models of ulcerative enterocolitis; lesions developed by chemotherapeutic agents; peritoneal, subcutaneous, pulmonary, and cardiac inflammation induced by biological and chemical agents; and atherosclerosis.</p><p>In recent years, some reports relate pathogen infection to the development and progression of chronic inflammation. In this systematic review, we found 9 studies reporting inflammatory conditions induced by microorganisms or their components, including LPS from <italic>E. coli</italic>, complete Freund's adjuvant, <italic>S. flexneri</italic>, and <italic>P. multocida</italic> [<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B50" ref-type="bibr">50</xref>]. LPS is the major cause of endotoxemia and sepsis. Toll-like receptor 4 (TLR4) is the main way to activate the inflammation pathway. Some authors suggest that LPS would stimulate inflammation by stimulating the production of reactive oxygen species, mainly by the production of superoxide anion (O<sub>2</sub><sup>&#x02212;</sup>); these factors activate for example the MAPK pathway that will trigger cellular responses to increase the production of proinflammatory cytokines to evoke the immune system to fight the injury [<xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B70" ref-type="bibr">70</xref>].</p><p>In addition, administration of LPS or microorganisms induces transcription factor NF-<italic>&#x003ba;</italic>B for initiating and sustaining inflammatory reactions. In the cell cytoplasm, NF-<italic>&#x003ba;</italic>B is inactivated by the interaction with newly synthesized protein inhibitory <italic>&#x003ba;</italic>B (I<italic>&#x003ba;</italic>B), in the TLR4 signaling-promoted dissociation of complex I<italic>&#x003ba;</italic>B-NF-<italic>&#x003ba;</italic>B and translocation of NF-<italic>&#x003ba;</italic>B into the nucleus from the cytoplasm to induce gene transcription of cytokines and chemokines [<xref rid="B71" ref-type="bibr">71</xref>].</p><p>Another widely used model corresponds to the evaluation of inflammatory bowel disease (IBD), for which several pharmacological models are employed, such as induction of ulcers by <italic>S. flexneri</italic> strains, intestinal mucositis induced by chemotherapy, and enterocolitis induced by DMH [<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B51" ref-type="bibr">51</xref>]. These pathologies are characterized by an excessive response of the immune system of the intestinal mucosa, activating the production and release of inflammatory mediators, such as eicosanoids, cytokines, reactive oxygen species (ROS), and nitrogen. In addition, defense cells such as mast cells produce toxic superoxide anions in the inflammatory environment and recruit neutrophils generating excess ROS, proteolytic enzymes, and ROS that contribute to lipid peroxidation. Furthermore, activated macrophages, neutrophils, and mast cells express receptors for IL-1<italic>&#x003b2;</italic> and iNOS playing an important role in progression or persistence of intestinal lesion [<xref rid="B72" ref-type="bibr">72</xref>&#x02013;<xref rid="B74" ref-type="bibr">74</xref>].</p><p>Involvement of inflammation in the pathogenesis of atherosclerosis is also well documented. Inflammatory cell types such as T-cells, monocytes, and neutrophils play major roles in mediating the inflammatory response in atherosclerosis. The deposition of lipid and oxidized low-density lipoprotein contributes to the initial and prolongated inflammatory response, especially in lipid oxidation, which is taken up by macrophages, dendritic cells, and smooth muscle cells to form lipid-laden foam cells. In addition, cells of the immune system participate to the inflammatory process producing proinflammatory cytokines IL-1 and TNF-<italic>&#x003b1;</italic>, mediators associated with reactive oxygen species- (ROS-) and nitric oxide- (NO-) (in excess) induced expression of adhesion molecules, and potentiate inflammation within the atherosclerotic lesion, which induces the chemoattraction of defense cells [<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B75" ref-type="bibr">75</xref>&#x02013;<xref rid="B77" ref-type="bibr">77</xref>].</p><p>Other experimental models have been well reported to assess chronic inflammation, such as cotton-pellet-induced granuloma, subcutaneous air pouch, and formalin test. However, these tests present low similarity to the previously described models in relation to the ability to resemble specific human inflammations, since they reproduce the general aspects of the chronic inflammatory process [<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B38" ref-type="bibr">38</xref>].</p><p>The formalin test is commonly described in acute inflammation tests; however, repeated application was described in the studies of Jeena et al. [<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B35" ref-type="bibr">35</xref>]. The inflammatory process is a result of tissue and functional alterations in the tissue accompanied by the release of inflammatory mediators such as histamine, prostaglandins, nitric oxide, and cytokines. To evaluate this, the authors monitor the reduction of edema and perform dosage of the involved mediators [<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B78" ref-type="bibr">78</xref>, <xref rid="B79" ref-type="bibr">79</xref>].</p><p>The granulomatous tissue induced by the subcutaneous cotton implant is a widely used method for the assessment of anti-inflammatory substance in chronic inflammation. This type of inflammation is a result of several infectious, autoimmune, toxic, allergic, and neoplastic conditions, characterized by the presence of mononuclear leukocytes, specifically macrophages, which respond to several chemical mediators of cell damage, most often forming multinucleated giant cells. In the injured tissue, some histological patterns are observed, such as edema, neovascularization, and early-stage fibrosis [<xref rid="B80" ref-type="bibr">80</xref>, <xref rid="B81" ref-type="bibr">81</xref>].</p></sec><sec id="sec3.6"><title>3.6. Role of Antioxidants in Chronic Inflammation</title><p>Free radicals correspond to a molecule or atom that carries unpaired electrons that makes them highly reactive and unstable and can cause cell damage. In normal cell metabolism, many free radicals are produced, which serve important functions in the signaling of specific pathophysiological pathways, the great majority of these radicals being produced in the mitochondrial metabolism. Examples of these are hydroxyl radical, superoxide anion, hydrogen peroxide, and organic peroxides. In addition, in the absence or low concentrations of oxygen, excessive lipid peroxidation occurs and mitochondria also generate nitric oxide (NO), which can generate reactive nitrogen species, which can produce other reactive species such as malondialdehyde [<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B82" ref-type="bibr">82</xref>, <xref rid="B83" ref-type="bibr">83</xref>].</p><p>In the inflammatory process, defensive cells located in injured regions lead to a &#x0201c;respiratory burst&#x0201d; in the tissue resulting from increased uptake of oxygen and, therefore, increased production and release of ROS in the damaged area. The release of mediators by these cells associated with the presence of ROS and RNS stimulates signal transduction cascades and alters transcription factors, such as NF-<italic>&#x003ba;</italic>B, which mediate vital reactions of cellular stress, leading to expression of COX-2, iNOS, and proinflammatory cytokines. Metabolites generated in inflammation associated with oxidative stress impair healthy tissue by altering the stroma and surrounding epithelial cells, which after a long period of time can evolve into more serious problems and trigger, for example, carcinogenesis [<xref rid="B84" ref-type="bibr">84</xref>, <xref rid="B85" ref-type="bibr">85</xref>].</p><p>In general, the body has an enzymatic system to combat the damage caused by oxidative stress. Three major antioxidants are the first line of defense against oxidative stress: superoxide dismutase, catalase, and glutathione peroxidase, being antioxidants commonly measured in the investigation of the antioxidant activity of natural compounds [<xref rid="B86" ref-type="bibr">86</xref>, <xref rid="B87" ref-type="bibr">87</xref>].</p><p>SOD enzyme, which converts highly reactive superoxide radicals in hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) and molecular oxygen [<xref rid="B86" ref-type="bibr">86</xref>], performs a first antioxidant defense in an oxidative stress situation [<xref rid="B88" ref-type="bibr">88</xref>]. Catalase also participates in this defense process, catalyzing the conversion of hydrogen peroxide (highly reactive) to water and molecular oxygen, being located mainly in the peroxisomes [<xref rid="B89" ref-type="bibr">89</xref>]. Glutathione exists in two forms with different subunits and different active sites. Glutathione peroxidase catalyzes the reduction of H<sub>2</sub>O<sub>2</sub> or organic peroxides (ROOH) to water or alcohol by the presence of GSH, which is converted to oxidize glutathione during this reaction. The main function of this latter enzyme is the protection of the polyunsaturated cell membranes [<xref rid="B87" ref-type="bibr">87</xref>].</p><p>In the articles reported in this study, the authors correlated the antioxidant tests with the anti-inflammatory activity of the essential oils and substances tested. For this, isolated tests of <italic>in vitro</italic> antioxidant activity, such as DPPH, inhibition of <italic>&#x003b2;</italic>-carotene degradation, ABTS, NO, and FRAP tests, were used as initial screening of the pharmacological activity of EOs or isolated substances. Based on the satisfactory results obtained, some anti-inflammatory activity tests were subsequently conducted [<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B29" ref-type="bibr">29</xref>&#x02013;<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B50" ref-type="bibr">50</xref>]. In contrast, other studies, especially <italic>in vivo</italic> studies, assessed the anti-inflammatory activity and at the end of the experiment the animals were euthanized and blood collected for serum levels indicating enzymes of oxidative stress. In these models, the analyses of superoxide dismutase, catalase, glutathione, malondialdehyde, and lipid peroxidation were mostly described [<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B49" ref-type="bibr">49</xref>].</p></sec><sec id="sec3.7"><title>3.7. Essential Oils with Antioxidant Properties in the Treatment of Chronic Inflammation</title><p>In view of the wide use of traditional medicine associated with its importance in drug discovery, EOs have been studied and their compounds identified/isolated components due to their diverse pharmacological properties, including the treatment of acute and chronic inflammation justified by their antioxidant properties [<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>]. EOs are volatile compounds that may contain more than 300 different compounds. Most of chemical constituents are terpenes, especially mono- and sesquiterpenes, but some nonterpene compounds biosynthesized by the phenylpropanoid pathway can also be present in EOs [<xref rid="B14" ref-type="bibr">14</xref>]. <xref ref-type="fig" rid="fig4"> Figure 4</xref> shows the major constituents of the EOs reported in this study, and <xref ref-type="fig" rid="fig5">Figure 5</xref> shows the isolated constituents with antioxidant activity tested in chronic inflammation models.</p><p>The anti-inflammatory and antioxidant activities of species and natural compounds were reported in the studies included in this article, where numerous preclinical cstudies presented promising results. In the experiments using peritoneal macrophages (Raw 264.7, <italic>in vitro</italic>), EOs obtained from <italic>O. crocata</italic>, <italic>O. quixo</italic>, <italic>C. intratropica</italic>, <italic>C. reticulata</italic>, <italic>H. sabdariffa</italic>, <italic>C. obtusa</italic>, and <italic>C. aurantium</italic> were able to reduce the levels of ROS considerably reducing tissue inflammation and RNS that cause tissue damage. In addition, EO of <italic>H. sabdariffa</italic> and <italic>C. aurantium</italic> inhibited NF-<italic>&#x003ba;</italic>B and MAPK signaling and promoted the decrease in the expression of transcription factors for the production of cytokines IL-1<italic>&#x003b2;</italic>, IL-6, and TNF-<italic>&#x003b1;</italic>. In addition, these EOs decreased the expression of cyclooxygenase-2 and iNOS enzymes [<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B48" ref-type="bibr">48</xref>].</p><p>
<italic>In vivo</italic> tests indicated that the treatment with ginger and <italic>P. nigrum</italic> EOs presents the ability to sequester superoxide, DPPH, and hydroxyl radicals, in addition to inhibiting lipid peroxidation, associated with the reduction in edema induced by chronic administration of formalin in paw tissue. In this way, the decrease in the inflammatory process occurs due to the increase in the activity of antioxidant enzymes SOD and glutathione [<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B35" ref-type="bibr">35</xref>]. In contrast, <italic>C. aurantium</italic> and <italic>C. ternata</italic> reduced defense cell migration and edema and reduced the levels of nitric oxide in the inflammatory exudate in a granuloma model. In inflammation induced by biological agents such as <italic>E. coli</italic> LPS, treatment with EO of <italic>N. sativa</italic> increased SOD and CAT expression and reduced nitric oxide and malondialdehyde levels [<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B33" ref-type="bibr">33</xref>].</p><p>
<italic>P. integerrima</italic> presented potential antiasthmatic activity in preclinical studies. This activity is related to inhibition of the degranulation of mast cell and inhibition of 5-LOX, where treatment with EO considerably reduced the number of total leukocytes in bronchoalveolar lavage fluid and pulmonary levels of myeloperoxidase. Associated with this, the plant presented antioxidant potential in the DPPH test, indicating satisfactory results for the treatment of chronic pulmonary diseases with possible involvement of oxidative pathways [<xref rid="B31" ref-type="bibr">31</xref>].</p><p>Articles that report the pharmacological evaluation of the essential oil of <italic>Z. cassumunar</italic> in encapsulated niosome by therapeutic ultrasound were also found in the searches. The encapsulated niosomes were applied in the skin and subsequently evaluated using ultrasound therapy to potentiate the anti-inflammatory action of the EO, favoring the absorption by the skin and subsequent action on the inflammation induced by repeated administration of LPS. The anti-inflammatory action of this oil is probably related to the presence of sabinene and terpinen-4-ol (major compounds) which reduce the expression of NF-<italic>&#x003ba;</italic>B and interleukin-6. The antioxidant tests indicated antioxidant activity of the EO, which inhibited DPPH radical, demonstrating once again the relation of inflammatory processes and antioxidant mechanisms [<xref rid="B50" ref-type="bibr">50</xref>].</p><p>In relation to the majority compounds studied, most are classified as monoterpenes, such as carvacrol, thymol, L-carveol, L-carvone, and m-cymene (<xref ref-type="fig" rid="fig6">Figure 6</xref>).</p><p>The carvacrol (5-isopropyl-2-methylphenol) is a phenolic monoterpene present in EOs of various species especially the Lamiaceae family, which presented pharmacological potentials, such as antioxidant and anti-inflammatory [<xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B91" ref-type="bibr">91</xref>]. The compound was the most reported in the studies included in this article, exhibiting activity in preclinical models of inflammatory diseases of the gastrointestinal tract, such as chemotherapy-induced mucositis and DMH-induced colitis. Its pharmacological activity in the mentioned models is a result of reduced expression of NF-<italic>&#x003ba;</italic>B, COX-2, and iNOS, associated with decreased levels of IL-1<italic>&#x003b2;</italic>, TNF-<italic>&#x003b1;</italic>, and NO. The treatment was also able to increase the antioxidant enzymes SOD, CAT, MDA, and GSH [<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B51" ref-type="bibr">51</xref>].</p><p>Anethole (1-methoxy-4-benzene-[1-propenyl]) is an aromatic compound used in the industry, which has antioxidant, antibacterial, antifungal, and anti-inflammatory potential [<xref rid="B92" ref-type="bibr">92</xref>, <xref rid="B93" ref-type="bibr">93</xref>]. Oral treatment with anethole inhibited complete Freund adjuvant-induced paw edema, in addition to reducing myeloperoxidase levels, TNF-<italic>&#x003b1;</italic>, IL-1<italic>&#x003b2;</italic>, and IL-17, thereby reducing the levels of ROS in the injured tissue [<xref rid="B25" ref-type="bibr">25</xref>].</p><p>Another terpene described in the articles was linalool (3,7-dimethylocta-1,6-dien-3-ol), which was investigated to assess its ability to reduce <italic>P. multocida</italic>-induced lung inflammation. Repeated subcutaneous administration of linalool reduced the levels of TNF-<italic>&#x003b1;</italic> and IL-6 and the number of polymorphs (neutrophils) in lung tissue, associated with an increase in SOD [<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B94" ref-type="bibr">94</xref>]. Eucalyptol (1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane) was also evaluated in a model of chronic lung inflammation induced by repeated exposure to cigarette smoke, where the treatment reduced the expression of NF-<italic>&#x003ba;</italic>B and consequently the levels of proinflammatory cytokines, promoting the reduction of the presence of leukocytes in the pulmonary alveoli. The levels of antioxidant enzymes SOD, CAT, MDA, and GSH, as well as total ROS were reduced [<xref rid="B46" ref-type="bibr">46</xref>].</p><p>In the experimental models, cinnamaldehyde, <italic>&#x003b2;</italic>-elemene, and thymol were evaluated in LPS-induced cardiac inflammation or hyperlipidic diet. Cinnamaldehyde possesses potent anti-inflammation effects on endotoxemia [<xref rid="B94" ref-type="bibr">94</xref>]. Zhao et al. [<xref rid="B44" ref-type="bibr">44</xref>] showed that cinnamaldehyde inhibited inflammatory infiltration and the levels of TNF-<italic>&#x003b1;</italic>, IL-1<italic>&#x003b2;</italic>, and IL-6 in LPS-stimulated rats by blocking the TLR4 and MAPK pathways, associated with the reduction in ROS levels in cardiac tissue [<xref rid="B44" ref-type="bibr">44</xref>]. <italic>&#x003b2;</italic>-Elemene also showed activity in the cardiac inflammation model. In this evaluation, treatment of apolipoprotein E (ApoE) knockout mice with <italic>&#x003b2;</italic>-elemene inhibited atherosclerotic lesions by reducing levels of nitric oxide, cytokines, and oxidative stress indicators and reversing the intracellular ROS production and MAPK signaling activation [<xref rid="B49" ref-type="bibr">49</xref>].</p><p>Thymol (2-isopropyl-5-methylphenol) was evaluated in two different models, inflammation in aortic intimal and imiquimod-induced psoriasis. In the first model, the antioxidant tests were evaluated <italic>in vitro</italic> DPPH and ABTS radical scavenging assay, demonstrating high antioxidant activity. The treatment also reduced lipid peroxidation <italic>in vivo</italic>, reducing serum levels of malondialdehyde. In relation to the parameters of anti-inflammatory activity, thymol reduced the expression of vascular adhesion molecules (VCAM), thus reducing leukocyte migration and proinflammatory cytokines [<xref rid="B45" ref-type="bibr">45</xref>]. Thus, the results suggest that this monoterpene reduced the oxidative stress, the putative mechanism involved in the pathogenesis of endothelial dysfunction, an early key event in the progression of atherosclerosis [<xref rid="B95" ref-type="bibr">95</xref>].</p><p>Nanoparticles containing thymol were also evaluated, using experimental models that mimic psoriasis. For this, anthralin (1,8-dihydroxy-9-anthrone), a drug used to treat psoriasis, was used for inducing inflammation in healthy skin mice and the antioxidant activity was evaluated after exposition to light, generators, and oxidative stress events. Thymol in nanoparticles showed better inhibition of edema by reducing inflammatory cells in inflamed tissue when compared to free thymol, indicating that nanoparticles improve anti-inflammatory activity mediated by mechanisms that inhibit the formation of reactive oxygen species [<xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B96" ref-type="bibr">96</xref>].</p><p>In general, the results of the studies indicated that EOs and/or their compounds presented pharmacological properties through the blockade of mitogen-activated protein kinase (MAPK) pathways, blocking NF-<italic>&#x003ba;</italic>B activation by mechanisms associated with the reduction of oxidative stress, leading to the reduction in the production of several proinflammatory mediators (<xref ref-type="fig" rid="fig6">Figure 6</xref>).</p></sec></sec><sec id="sec4"><title>4. Conclusion and Perspectives</title><p>This systematic review suggests that EOs and their major compounds have a potential for the treatment of inflammatory diseases especially in chronic inflammatory conditions. The main action targets presented in this review for the therapy of chronic inflammations were the reduction in reactive oxygen and nitrogen species and the reduction in NF-<italic>&#x003ba;</italic>B reducing the expression of proinflammatory cytokines.</p><p>
<italic>In vivo</italic> tests reported various models of inflammation that resemble human pathologies, including assessment of their mechanism of action, antioxidant enzyme dosages, and molecular effects of EOs. Regarding the rigor of design and study data included in this review, most of the studies presented moderate quality indicating that some aspects still need to be improved but in general provide evidence of the anti-inflammatory potential associated with the antioxidant activity of EOs.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors acknowledge the financial support from the Brazilian agencies CNPq, CAPES, FACEPE, and State University of Feira de Santana (UEFS).</p></ack><sec><title>Conflicts of Interest</title><p>The authors declare that there is no conflict of interest regarding the publication of this paper.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolaczkowska</surname><given-names>E.</given-names></name><name><surname>Kubes</surname><given-names>P.</given-names></name></person-group><article-title>Neutrophil recruitment and function in health and inflammation</article-title><source><italic toggle="yes">Nature Reviews Immunology</italic></source><year>2013</year><volume>13</volume><issue>3</issue><fpage>159</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1038/nri3399</pub-id><pub-id pub-id-type="other">2-s2.0-84875442814</pub-id><?supplied-pmid 23435331?><pub-id pub-id-type="pmid">23435331</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vendramini-Costa</surname><given-names>D. B.</given-names></name><name><surname>Carvalho</surname><given-names>J. E.</given-names></name></person-group><article-title>Molecular link mechanisms between inflammation and cancer</article-title><source><italic toggle="yes">Current Pharmaceutical Design</italic></source><year>2012</year><volume>18</volume><issue>26</issue><fpage>3831</fpage><lpage>3852</lpage><pub-id pub-id-type="doi">10.2174/138161212802083707</pub-id><pub-id pub-id-type="other">2-s2.0-84864545633</pub-id><pub-id pub-id-type="pmid">22632748</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammerschmidt</surname><given-names>S. I.</given-names></name><name><surname>Ahrendt</surname><given-names>M.</given-names></name><name><surname>Bode</surname><given-names>U.</given-names></name><etal/></person-group><article-title>Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo</article-title><source><italic toggle="yes">Journal of Experimental Medicine</italic></source><year>2008</year><volume>205</volume><issue>11</issue><fpage>2483</fpage><lpage>2490</lpage><pub-id pub-id-type="doi">10.1084/jem.20080039</pub-id><pub-id pub-id-type="other">2-s2.0-58149145656</pub-id><?supplied-pmid 18852290?><pub-id pub-id-type="pmid">18852290</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kodydkova</surname><given-names>J.</given-names></name><name><surname>Vavrova</surname><given-names>L.</given-names></name><name><surname>Stankova</surname><given-names>B.</given-names></name><name><surname>Macasek</surname><given-names>J.</given-names></name><name><surname>Krechler</surname><given-names>T.</given-names></name><name><surname>Zak</surname><given-names>A.</given-names></name></person-group><article-title>Antioxidant status and oxidative stress markers in pancreatic cancer and chronic pancreatitis</article-title><source><italic toggle="yes">Pancreas</italic></source><year>2013</year><volume>42</volume><issue>4</issue><fpage>614</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1097/MPA.0b013e318288360a</pub-id><pub-id pub-id-type="other">2-s2.0-84876879365</pub-id><?supplied-pmid 23558240?><pub-id pub-id-type="pmid">23558240</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>M. E.</given-names></name><name><surname>Khan</surname><given-names>M. M.</given-names></name><name><surname>Javed</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Amelioration of cognitive impairment and neurodegeneration by catechin hydrate in rat model of streptozotocin-induced experimental dementia of Alzheimer&#x02019;s type</article-title><source><italic toggle="yes">Neurochemistry International</italic></source><year>2013</year><volume>62</volume><issue>4</issue><fpage>492</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2013.02.006</pub-id><pub-id pub-id-type="other">2-s2.0-84874611828</pub-id><?supplied-pmid 23411413?><pub-id pub-id-type="pmid">23411413</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Zhao</surname><given-names>J. J.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Feng</surname><given-names>F.</given-names></name><name><surname>Qu</surname><given-names>W.</given-names></name></person-group><article-title>Medicinal uses, phytochemistry and pharmacology of the genus <italic>Uncaria</italic></article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2015</year><volume>173</volume><fpage>48</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2015.06.011</pub-id><pub-id pub-id-type="other">2-s2.0-84938076667</pub-id><?supplied-pmid 26091967?><pub-id pub-id-type="pmid">26091967</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grivennikov</surname><given-names>S. I.</given-names></name><name><surname>Greten</surname><given-names>F. R.</given-names></name><name><surname>Karin</surname><given-names>M.</given-names></name></person-group><article-title>Immunity, inflammation and cancer</article-title><source><italic toggle="yes">Cell</italic></source><year>2010</year><volume>140</volume><issue>6</issue><fpage>883</fpage><lpage>899</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.01.025</pub-id><pub-id pub-id-type="other">2-s2.0-77950346282</pub-id><?supplied-pmid 20303878?><pub-id pub-id-type="pmid">20303878</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kundu</surname><given-names>J. K.</given-names></name><name><surname>Surh</surname><given-names>Y. J.</given-names></name></person-group><article-title>Emerging avenues linking inflammation and cancer</article-title><source><italic toggle="yes">Free Radical Biology &#x00026; Medicine</italic></source><year>2012</year><volume>52</volume><issue>9</issue><fpage>2013</fpage><lpage>2037</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.02.035</pub-id><pub-id pub-id-type="other">2-s2.0-84859635458</pub-id><?supplied-pmid 22391222?><pub-id pub-id-type="pmid">22391222</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>A.</given-names></name><name><surname>Fernandes</surname><given-names>E.</given-names></name><name><surname>Lima</surname><given-names>J.</given-names></name><name><surname>Mira</surname><given-names>L.</given-names></name><name><surname>Corvo</surname><given-names>M.</given-names></name></person-group><article-title>Molecular mechanisms of anti-inflammatory activity mediated by flavonoids</article-title><source><italic toggle="yes">Current Medicinal Chemistry</italic></source><year>2008</year><volume>15</volume><issue>16</issue><fpage>1586</fpage><lpage>1605</lpage><pub-id pub-id-type="doi">10.2174/092986708784911579</pub-id><pub-id pub-id-type="other">2-s2.0-48249112172</pub-id><?supplied-pmid 18673226?><pub-id pub-id-type="pmid">18673226</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>J.</given-names></name><name><surname>Seki</surname><given-names>T.</given-names></name><name><surname>Maeda</surname><given-names>H.</given-names></name></person-group><article-title>Therapeutic strategies by modulating oxygen stress in cancer and inflammation</article-title><source><italic toggle="yes">Advanced Drug Delivery Reviews</italic></source><year>2009</year><volume>61</volume><issue>4</issue><fpage>290</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2009.02.005</pub-id><pub-id pub-id-type="other">2-s2.0-64149087422</pub-id><?supplied-pmid 19249331?><pub-id pub-id-type="pmid">19249331</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reuter</surname><given-names>S.</given-names></name><name><surname>Gupta</surname><given-names>S. C.</given-names></name><name><surname>Chaturvedi</surname><given-names>M. M.</given-names></name><name><surname>Aggarwal</surname><given-names>B. B.</given-names></name></person-group><article-title>Oxidative stress, inflammation, and cancer: how are they linked?</article-title><source><italic toggle="yes">Free Radical Biology &#x00026; Medicine</italic></source><year>2010</year><volume>49</volume><issue>11</issue><fpage>1603</fpage><lpage>1616</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2010.09.006</pub-id><pub-id pub-id-type="other">2-s2.0-78049370987</pub-id><?supplied-pmid 20840865?><pub-id pub-id-type="pmid">20840865</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Federico</surname><given-names>A.</given-names></name><name><surname>Morgillo</surname><given-names>F.</given-names></name><name><surname>Tuccillo</surname><given-names>C.</given-names></name><name><surname>Ciardiello</surname><given-names>F.</given-names></name><name><surname>Loguercio</surname><given-names>C.</given-names></name></person-group><article-title>Chronic inflammation and oxidative stress in human carcinogenesis</article-title><source><italic toggle="yes">International Journal of Cancer</italic></source><year>2007</year><volume>121</volume><issue>11</issue><fpage>2381</fpage><lpage>2386</lpage><pub-id pub-id-type="doi">10.1002/ijc.23192</pub-id><pub-id pub-id-type="other">2-s2.0-35648946229</pub-id><?supplied-pmid 17893868?><pub-id pub-id-type="pmid">17893868</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Antony</surname><given-names>S.</given-names></name><name><surname>Meitzler</surname><given-names>J. L.</given-names></name><name><surname>Doroshow</surname><given-names>J. H.</given-names></name></person-group><article-title>Molecular mechanisms underlying chronic inflammation-associated cancers</article-title><source><italic toggle="yes">Cancer Letters</italic></source><year>2014</year><volume>345</volume><issue>2</issue><fpage>164</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2013.08.014</pub-id><pub-id pub-id-type="other">2-s2.0-84896729229</pub-id><?supplied-pmid 23988267?><pub-id pub-id-type="pmid">23988267</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubiolo</surname><given-names>P.</given-names></name><name><surname>Sgorbini</surname><given-names>B.</given-names></name><name><surname>Liberto</surname><given-names>E.</given-names></name><name><surname>Cordero</surname><given-names>C.</given-names></name><name><surname>Bicchi</surname><given-names>C.</given-names></name></person-group><article-title>Essential oils and volatiles: sample preparation and analysis. A review</article-title><source><italic toggle="yes">Flavour and Fragrance Journal</italic></source><year>2010</year><volume>25</volume><issue>5</issue><fpage>282</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1002/ffj.1984</pub-id><pub-id pub-id-type="other">2-s2.0-78650674359</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bicchi</surname><given-names>C.</given-names></name><name><surname>Liberto</surname><given-names>E.</given-names></name><name><surname>Matteodo</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Quantitative analysis of essential oils: a complex task</article-title><source><italic toggle="yes">Flavour and Fragrance Journal</italic></source><year>2008</year><volume>23</volume><issue>6</issue><fpage>382</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1002/ffj.1905</pub-id><pub-id pub-id-type="other">2-s2.0-59849124597</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakkali</surname><given-names>F.</given-names></name><name><surname>Averbeck</surname><given-names>S.</given-names></name><name><surname>Averbeck</surname><given-names>D.</given-names></name><name><surname>Idaomar</surname><given-names>M.</given-names></name></person-group><article-title>Biological effects of essential oils &#x02013; a review</article-title><source><italic toggle="yes">Food and Chemical Toxicology</italic></source><year>2008</year><volume>46</volume><issue>2</issue><fpage>446</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2007.09.106</pub-id><pub-id pub-id-type="other">2-s2.0-37349104213</pub-id><?supplied-pmid 17996351?><pub-id pub-id-type="pmid">17996351</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miguel</surname><given-names>M. G.</given-names></name></person-group><article-title>Antioxidant and anti-inflammatory activities of essential oils: a short review</article-title><source><italic toggle="yes">Molecules</italic></source><year>2010</year><volume>15</volume><issue>12</issue><fpage>9252</fpage><lpage>9287</lpage><pub-id pub-id-type="doi">10.3390/molecules15129252</pub-id><pub-id pub-id-type="other">2-s2.0-78650632257</pub-id><?supplied-pmid 21160452?><pub-id pub-id-type="pmid">21160452</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenard&#x000e3;o</surname><given-names>E. J.</given-names></name><name><surname>Savegnago</surname><given-names>L.</given-names></name><name><surname>Jacob</surname><given-names>R. G.</given-names></name><name><surname>Victoria</surname><given-names>F. N.</given-names></name><name><surname>Martinez</surname><given-names>D. M.</given-names></name></person-group><article-title>Antinociceptive effect of essential oils and their constituents: an update review</article-title><source><italic toggle="yes">Journal of the Brazilian Chemical Society</italic></source><year>2016</year><volume>27</volume><issue>3</issue><fpage>435</fpage><lpage>474</lpage><pub-id pub-id-type="doi">10.5935/0103-5053.20150332</pub-id><pub-id pub-id-type="other">2-s2.0-84960325648</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>L. L.</given-names></name><name><surname>Garlet</surname><given-names>Q. I.</given-names></name><name><surname>Benovit</surname><given-names>S. C.</given-names></name><etal/></person-group><article-title>Sedative and anesthetic activities of the essential oils of <italic>Hyptis mutabilis</italic> (Rich.) Briq. and their isolated components in silver catfish (<italic>Rhamdia quelen</italic>)</article-title><source><italic toggle="yes">Brazilian Journal of Medical and Biological Research</italic></source><year>2013</year><volume>46</volume><issue>9</issue><fpage>771</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1590/1414-431X20133013</pub-id><pub-id pub-id-type="other">2-s2.0-84884578919</pub-id><?supplied-pmid 24068193?><pub-id pub-id-type="pmid">24068193</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes Camp&#x000ea;lo</surname><given-names>L. M.</given-names></name><name><surname>Gon&#x000e7;alves e S&#x000e1;</surname><given-names>C.</given-names></name><name><surname>de Almeida</surname><given-names>A. A.</given-names></name><etal/></person-group><article-title>Sedative, anxiolytic and antidepressant activities of <italic>Citrus limon</italic> (Burn) essential oil in mice</article-title><source><italic toggle="yes">Die Pharmazie</italic></source><year>2011</year><volume>66</volume><issue>8</issue><fpage>623</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1691/ph.2011.1508</pub-id><pub-id pub-id-type="other">2-s2.0-80053309099</pub-id><pub-id pub-id-type="pmid">21901988</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooijmans</surname><given-names>C. R.</given-names></name><name><surname>Rovers</surname><given-names>M. M.</given-names></name><name><surname>de Vries</surname><given-names>R. B. M.</given-names></name><name><surname>Leenaars</surname><given-names>M.</given-names></name><name><surname>Ritskes-Hoitinga</surname><given-names>M.</given-names></name><name><surname>Langendam</surname><given-names>M. W.</given-names></name></person-group><article-title>SYRCLE&#x02019;s risk of bias tool for animal studies</article-title><source><italic toggle="yes">BMC Medical Research Methodology</italic></source><year>2014</year><volume>14</volume><issue>1</issue><fpage>p. 43</fpage><pub-id pub-id-type="doi">10.1186/1471-2288-14-43</pub-id><pub-id pub-id-type="other">2-s2.0-84907187721</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siqueira-Lima</surname><given-names>P. S.</given-names></name><name><surname>Silva</surname><given-names>J. C.</given-names></name><name><surname>Quintans</surname><given-names>J. S. S.</given-names></name><etal/></person-group><article-title>Natural products assessed in animal models for orofacial pain &#x02013; a systematic review</article-title><source><italic toggle="yes">Revista Brasileira de Farmacognosia</italic></source><year>2017</year><volume>27</volume><issue>1</issue><fpage>124</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1016/j.bjp.2016.06.005</pub-id><pub-id pub-id-type="other">2-s2.0-85009812139</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Kwong</surname><given-names>J. S. W.</given-names></name><etal/></person-group><article-title>The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review</article-title><source><italic toggle="yes">Journal of Evidence Based Medicine</italic></source><year>2015</year><volume>8</volume><issue>1</issue><fpage>2</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1111/jebm.12141</pub-id><pub-id pub-id-type="other">2-s2.0-84925295147</pub-id><?supplied-pmid 25594108?><pub-id pub-id-type="pmid">25594108</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>M. L.</given-names></name><name><surname>Lin</surname><given-names>C. C.</given-names></name><name><surname>Lin</surname><given-names>W. C.</given-names></name><name><surname>Yang</surname><given-names>C. H.</given-names></name></person-group><article-title>Antimicrobial, antioxidant and anti-inflammatory activities of essential oils from five selected herbs</article-title><source><italic toggle="yes">Bioscience, Biotechnology, and Biochemistry</italic></source><year>2014</year><volume>75</volume><issue>10</issue><fpage>1977</fpage><lpage>1983</lpage><pub-id pub-id-type="doi">10.1271/bbb.110377</pub-id><pub-id pub-id-type="other">2-s2.0-80054950439</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritter</surname><given-names>A. M. V.</given-names></name><name><surname>Domiciano</surname><given-names>T. P.</given-names></name><name><surname>Verri</surname><given-names>W. A.</given-names></name><etal/></person-group><article-title>Antihypernociceptive activity of anethole in experimental inflammatory pain</article-title><source><italic toggle="yes">Inflammopharmacology</italic></source><year>2013</year><volume>21</volume><issue>2</issue><fpage>187</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1007/s10787-012-0152-6</pub-id><pub-id pub-id-type="other">2-s2.0-84879502240</pub-id><?supplied-pmid 23054333?><pub-id pub-id-type="pmid">23054333</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeena</surname><given-names>K.</given-names></name><name><surname>Liju</surname><given-names>V. B.</given-names></name><name><surname>Kuttan</surname><given-names>R.</given-names></name></person-group><article-title>Antioxidant, anti-inflammatory and antinociceptive activities of essential oil from ginger</article-title><source><italic toggle="yes">Indian Journal of Physiology and Pharmacology</italic></source><year>2013</year><volume>57</volume><issue>1</issue><fpage>51</fpage><lpage>62</lpage><?supplied-pmid 24020099?><pub-id pub-id-type="pmid">24020099</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Readi</surname><given-names>M. Z.</given-names></name><name><surname>Eid</surname><given-names>H. H.</given-names></name><name><surname>Ashour</surname><given-names>M. L.</given-names></name><etal/></person-group><article-title>Variations of the chemical composition and bioactivity of essential oils from leaves and stems of <italic>Liquidambar styraciflua</italic> (Altingiaceae)</article-title><source><italic toggle="yes">Journal of Pharmacy and Pharmacology</italic></source><year>2013</year><volume>65</volume><issue>11</issue><fpage>1653</fpage><lpage>1663</lpage><pub-id pub-id-type="doi">10.1111/jphp.12142</pub-id><pub-id pub-id-type="other">2-s2.0-84886088387</pub-id><?supplied-pmid 24117424?><pub-id pub-id-type="pmid">24117424</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valente</surname><given-names>J.</given-names></name><name><surname>Zuzarte</surname><given-names>M.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>M. J.</given-names></name><etal/></person-group><article-title>Antifungal, antioxidant and anti-inflammatory activities of <italic>Oenanthe crocata</italic> L. essential oil</article-title><source><italic toggle="yes">Food and Chemical Toxicology</italic></source><year>2013</year><volume>62</volume><fpage>349</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2013.08.083</pub-id><pub-id pub-id-type="other">2-s2.0-84884361020</pub-id><?supplied-pmid 24012643?><pub-id pub-id-type="pmid">24012643</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>J.</given-names></name><name><surname>Cai</surname><given-names>Q. Y.</given-names></name><name><surname>Xu</surname><given-names>W.</given-names></name><name><surname>Lin</surname><given-names>J. M.</given-names></name><name><surname>Peng</surname><given-names>J.</given-names></name></person-group><article-title>Chemical composition, anticancer, anti-neuroinflammatory, and antioxidant activities of the essential oil of <italic>Patrinia scabiosaefolia</italic></article-title><source><italic toggle="yes">Chinese Journal of Integrative Medicine</italic></source><year>2018</year><volume>24</volume><issue>3</issue><fpage>207</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1007/s11655-016-2459-4</pub-id><pub-id pub-id-type="other">2-s2.0-84984815964</pub-id><?supplied-pmid 27586471?><pub-id pub-id-type="pmid">27586471</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Destryana</surname><given-names>R. A.</given-names></name><name><surname>Young</surname><given-names>D. G.</given-names></name><name><surname>Woolley</surname><given-names>C. L.</given-names></name><name><surname>Huang</surname><given-names>T.-C.</given-names></name><name><surname>Wu</surname><given-names>H.-Y.</given-names></name><name><surname>Shih</surname><given-names>W.-L.</given-names></name></person-group><article-title>Antioxidant and anti-inflammation activities of Ocotea, Copaiba and Blue Cypress essential oils in vitro and in vivo</article-title><source><italic toggle="yes">Journal of the American Oil Chemists' Society</italic></source><year>2014</year><volume>91</volume><issue>9</issue><fpage>1531</fpage><lpage>1542</lpage><pub-id pub-id-type="doi">10.1007/s11746-014-2504-4</pub-id><pub-id pub-id-type="other">2-s2.0-84940234916</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirole</surname><given-names>R. L.</given-names></name><name><surname>Shirole</surname><given-names>N. L.</given-names></name><name><surname>Kshatriya</surname><given-names>A. A.</given-names></name><name><surname>Kulkarni</surname><given-names>R.</given-names></name><name><surname>Saraf</surname><given-names>M. N.</given-names></name></person-group><article-title>Investigation into the mechanism of action of essential oil of <italic>Pistacia integerrima</italic> for its antiasthmatic activity</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2014</year><volume>153</volume><issue>3</issue><fpage>541</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2014.02.009</pub-id><pub-id pub-id-type="other">2-s2.0-84900321824</pub-id><?supplied-pmid 24556221?><pub-id pub-id-type="pmid">24556221</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patil</surname><given-names>N. R.</given-names></name><name><surname>Rasal</surname><given-names>V. P.</given-names></name><name><surname>Malabade</surname><given-names>R. H.</given-names></name></person-group><article-title>Screening of mandarin oil on indomethcin induced inflammatory bowel disease in wistar rats</article-title><source><italic toggle="yes">Indian Journal of Pharmaceutical Education and Research</italic></source><year>2014</year><volume>48</volume><issue>Supplementary</issue><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.5530/ijper.48.4s.1</pub-id><pub-id pub-id-type="other">2-s2.0-84925354348</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khodabakhsh</surname><given-names>P.</given-names></name><name><surname>Shafaroodi</surname><given-names>H.</given-names></name><name><surname>Asgarpanah</surname><given-names>J.</given-names></name></person-group><article-title>Analgesic and anti-inflammatory activities of <italic>Citrus aurantium</italic> L. blossoms essential oil (neroli): involvement of the nitric oxide/cyclic-guanosine monophosphate pathway</article-title><source><italic toggle="yes">Journal of Natural Medicines</italic></source><year>2015</year><volume>69</volume><issue>3</issue><fpage>324</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1007/s11418-015-0896-6</pub-id><pub-id pub-id-type="other">2-s2.0-84930764821</pub-id><?supplied-pmid 25762161?><pub-id pub-id-type="pmid">25762161</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Q.</given-names></name><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Qiu</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Linalool attenuates lung inflammation induced by <italic>Pasteurella multocida</italic> via activating Nrf-2 signaling pathway</article-title><source><italic toggle="yes">International Immunopharmacology</italic></source><year>2014</year><volume>21</volume><issue>2</issue><fpage>456</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2014.05.030</pub-id><pub-id pub-id-type="other">2-s2.0-84902688662</pub-id><?supplied-pmid 24925757?><pub-id pub-id-type="pmid">24925757</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeena</surname><given-names>K.</given-names></name><name><surname>Liju</surname><given-names>V. B.</given-names></name><name><surname>Umadevi</surname><given-names>N. P.</given-names></name><name><surname>Kuttan</surname><given-names>R.</given-names></name></person-group><article-title>Antioxidant, anti-inflammatory and antinociceptive properties of black pepper essential oil (<italic>Piper nigrum</italic> Linn)</article-title><source><italic toggle="yes">Journal of Essential Oil Bearing Plants</italic></source><year>2014</year><volume>17</volume><issue>1</issue><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1080/0972060X.2013.831562</pub-id><pub-id pub-id-type="other">2-s2.0-84897646831</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Entok</surname><given-names>E.</given-names></name><name><surname>Ustuner</surname><given-names>M. C.</given-names></name><name><surname>Ozbayer</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Anti-inflammatuar and anti-oxidative effects of <italic>Nigella sativa</italic> L.: <sup>18</sup>FDG-PET imaging of inflammation</article-title><source><italic toggle="yes">Molecular Biology Reports</italic></source><year>2014</year><volume>41</volume><issue>5</issue><fpage>2827</fpage><lpage>2834</lpage><pub-id pub-id-type="doi">10.1007/s11033-014-3137-2</pub-id><pub-id pub-id-type="other">2-s2.0-84905679782</pub-id><?supplied-pmid 24474661?><pub-id pub-id-type="pmid">24474661</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazemi</surname><given-names>M.</given-names></name></person-group><article-title>Chemical composition and antimicrobial, antioxidant activities and anti-inflammatory potential of <italic>Achillea millefolium</italic> L., <italic>Anethum graveolens</italic> L., and <italic>Carum copticum</italic> L. essential oils</article-title><source><italic toggle="yes">Journal of Herbal Medicine</italic></source><year>2015</year><volume>5</volume><issue>4</issue><fpage>217</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1016/j.hermed.2015.09.001</pub-id><pub-id pub-id-type="other">2-s2.0-84945248472</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinheiro</surname><given-names>M. M. G.</given-names></name><name><surname>Miltojevi&#x00107;</surname><given-names>A. B.</given-names></name><name><surname>Radulovi&#x00107;</surname><given-names>N. S.</given-names></name><name><surname>Abdul-Wahab</surname><given-names>I. R.</given-names></name><name><surname>Boylan</surname><given-names>F.</given-names></name><name><surname>Fernandes</surname><given-names>P. D.</given-names></name></person-group><article-title>Anti-inflammatory activity of <italic>Choisya ternata</italic> Kunth essential oil, ternanthranin, and its two synthetic analogs (methyl and propyl <italic>N</italic>-methylanthranilates)</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2015</year><volume>10</volume><issue>3, article e0121063</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0121063</pub-id><pub-id pub-id-type="other">2-s2.0-84926025719</pub-id><?supplied-pmid 25807367?><pub-id pub-id-type="pmid">25807367</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kara</surname><given-names>M.</given-names></name><name><surname>Uslu</surname><given-names>S.</given-names></name><name><surname>Demirci</surname><given-names>F.</given-names></name><name><surname>Temel</surname><given-names>H. E.</given-names></name><name><surname>Baydemir</surname><given-names>C.</given-names></name></person-group><article-title>Supplemental carvacrol can reduce the severity of inflammation by influencing the production of mediators of inflammation</article-title><source><italic toggle="yes">Inflammation</italic></source><year>2015</year><volume>38</volume><issue>3</issue><fpage>1020</fpage><lpage>1027</lpage><pub-id pub-id-type="doi">10.1007/s10753-014-0066-0</pub-id><pub-id pub-id-type="other">2-s2.0-84939934480</pub-id><?supplied-pmid 25416233?><pub-id pub-id-type="pmid">25416233</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allam</surname><given-names>N. G.</given-names></name><name><surname>Eldrieny</surname><given-names>E. A. E. A.</given-names></name><name><surname>Mohamed</surname><given-names>A. Z.</given-names></name></person-group><article-title>Effect of combination therapy between thyme oil and ciprofloxacin on ulcer-forming <italic>Shigella flexneri</italic></article-title><source><italic toggle="yes">The Journal of Infection in Developing Countries</italic></source><year>2015</year><volume>9</volume><issue>05</issue><fpage>486</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.3855/jidc.6302</pub-id><pub-id pub-id-type="other">2-s2.0-84929576269</pub-id><pub-id pub-id-type="pmid">25989168</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>C. Y.</given-names></name><name><surname>Zhang</surname><given-names>T. T.</given-names></name><name><surname>Zhang</surname><given-names>W. L.</given-names></name><name><surname>Jiang</surname><given-names>J. G.</given-names></name></person-group><article-title>Anti-inflammatory activities of essential oil isolated from the calyx of <italic>Hibiscus sabdariffa</italic> L</article-title><source><italic toggle="yes">Food &#x00026; Function</italic></source><year>2016</year><volume>7</volume><issue>10</issue><fpage>4451</fpage><lpage>4459</lpage><pub-id pub-id-type="doi">10.1039/C6FO00795C</pub-id><pub-id pub-id-type="other">2-s2.0-84991490821</pub-id><?supplied-pmid 27713954?><pub-id pub-id-type="pmid">27713954</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>Y.</given-names></name><name><surname>Yoo</surname><given-names>S. A.</given-names></name><name><surname>Kim</surname><given-names>W. U.</given-names></name><name><surname>Cho</surname><given-names>C. S.</given-names></name><name><surname>Woo</surname><given-names>J. M.</given-names></name><name><surname>Yoon</surname><given-names>C. H.</given-names></name></person-group><article-title>Anti-inflammatory effects of essential oils extracted from <italic>Chamaecyparis obtusa</italic> on murine models of inflammation and RAW 264.7 cells</article-title><source><italic toggle="yes">Molecular Medicine Reports</italic></source><year>2016</year><volume>13</volume><issue>4</issue><fpage>3335</fpage><lpage>3341</lpage><pub-id pub-id-type="doi">10.3892/mmr.2016.4905</pub-id><pub-id pub-id-type="other">2-s2.0-84963811347</pub-id><?supplied-pmid 26936418?><pub-id pub-id-type="pmid">26936418</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ska&#x00142;a</surname><given-names>E.</given-names></name><name><surname>Rijo</surname><given-names>P.</given-names></name><name><surname>Garcia</surname><given-names>C.</given-names></name><etal/></person-group><article-title>The essential oils of <italic>Rhaponticum carthamoides</italic> hairy roots and roots of soil-grown plants: chemical composition and antimicrobial, anti-inflammatory, and antioxidant activities</article-title><source><italic toggle="yes">Oxidative Medicine and Cellular Longevity</italic></source><year>2016</year><volume>2016</volume><fpage>10</fpage><pub-id pub-id-type="doi">10.1155/2016/8505384</pub-id><pub-id pub-id-type="other">2-s2.0-85008953562</pub-id><pub-id pub-id-type="publisher-id">8505384</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Zhou</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Cinnamaldehyde ameliorates LPS-induced cardiac dysfunction via TLR4-NOX4 pathway: the regulation of autophagy and ROS production</article-title><source><italic toggle="yes">Journal of Molecular and Cellular Cardiology</italic></source><year>2016</year><volume>101</volume><fpage>11</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.yjmcc.2016.10.017</pub-id><pub-id pub-id-type="other">2-s2.0-85006827029</pub-id><?supplied-pmid 27838370?><pub-id pub-id-type="pmid">27838370</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y. M.</given-names></name><name><surname>Chao</surname><given-names>T. Y.</given-names></name><name><surname>Chang</surname><given-names>W. C.</given-names></name><name><surname>Chang</surname><given-names>M. J.</given-names></name><name><surname>Lee</surname><given-names>M. F.</given-names></name></person-group><article-title>Thymol reduces oxidative stress, aortic intimal thickening, and inflammation-related gene expression in hyperlipidemic rabbits</article-title><source><italic toggle="yes">Journal of Food and Drug Analysis</italic></source><year>2016</year><volume>24</volume><issue>3</issue><fpage>556</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1016/j.jfda.2016.02.004</pub-id><pub-id pub-id-type="other">2-s2.0-84964277229</pub-id><?supplied-pmid 28911561?><pub-id pub-id-type="pmid">28911561</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy-Feitosa</surname><given-names>E.</given-names></name><name><surname>Okuro</surname><given-names>R. T.</given-names></name><name><surname>Pinho Ribeiro</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Eucalyptol attenuates cigarette smoke-induced acute lung inflammation and oxidative stress in the mouse</article-title><source><italic toggle="yes">Pulmonary Pharmacology &#x00026; Therapeutics</italic></source><year>2016</year><volume>41</volume><fpage>11</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.pupt.2016.09.004</pub-id><pub-id pub-id-type="other">2-s2.0-84986292253</pub-id><?supplied-pmid 27599597?><pub-id pub-id-type="pmid">27599597</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarenga</surname><given-names>E. M.</given-names></name><name><surname>Souza</surname><given-names>L. K. M.</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>T. S. L.</given-names></name><etal/></person-group><article-title>Carvacrol reduces irinotecan-induced intestinal mucositis through inhibition of inflammation and oxidative damage via TRPA1 receptor activation</article-title><source><italic toggle="yes">Chemico-Biological Interactions</italic></source><year>2016</year><volume>260</volume><fpage>129</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2016.11.009</pub-id><pub-id pub-id-type="other">2-s2.0-84994890251</pub-id><?supplied-pmid 27838229?><pub-id pub-id-type="pmid">27838229</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>C. Y.</given-names></name><name><surname>Jiang</surname><given-names>J. G.</given-names></name><name><surname>Zhu</surname><given-names>W.</given-names></name><name><surname>Ou-Yang</surname><given-names>Q.</given-names></name></person-group><article-title>Anti-inflammatory effect of essential oil from <italic>Citrus aurantium</italic> L. var. <italic>amara</italic> Engl</article-title><source><italic toggle="yes">Journal of Agricultural and Food Chemistry</italic></source><year>2017</year><volume>65</volume><issue>39</issue><fpage>8586</fpage><lpage>8594</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.7b02586</pub-id><pub-id pub-id-type="other">2-s2.0-85032749072</pub-id><?supplied-pmid 28906110?><pub-id pub-id-type="pmid">28906110</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><etal/></person-group><article-title>
<italic>&#x003b2;</italic>-Elemene attenuates atherosclerosis in apolipoprotein E-deficient mice via restoring NO levels and alleviating oxidative stress</article-title><source><italic toggle="yes">Biomedicine &#x00026; Pharmacotherapy</italic></source><year>2017</year><volume>95</volume><fpage>1789</fpage><lpage>1798</lpage><pub-id pub-id-type="doi">10.1016/j.biopha.2017.08.092</pub-id><pub-id pub-id-type="other">2-s2.0-85029817888</pub-id><?supplied-pmid 28962084?><pub-id pub-id-type="pmid">28962084</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leelarungrayub</surname><given-names>J.</given-names></name><name><surname>Manorsoi</surname><given-names>J.</given-names></name><name><surname>Manorsoi</surname><given-names>A.</given-names></name></person-group><article-title>Anti-inflammatory activity of niosomes entrapped with Plai oil (<italic>Zingiber cassumunar</italic> Roxb.) by therapeutic ultrasound in a rat model</article-title><source><italic toggle="yes">International Journal of Nanomedicine</italic></source><year>2017</year><volume>12</volume><fpage>2469</fpage><lpage>2476</lpage><pub-id pub-id-type="doi">10.2147/IJN.S129131</pub-id><pub-id pub-id-type="other">2-s2.0-85017178009</pub-id><?supplied-pmid 28408818?><pub-id pub-id-type="pmid">28408818</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arigesavan</surname><given-names>K.</given-names></name><name><surname>Sudhandiran</surname><given-names>G.</given-names></name></person-group><article-title>Carvacrol exhibits anti-oxidant and anti-inflammatory effects against 1, 2-dimethyl hydrazine plus dextran sodium sulfate induced inflammation associated carcinogenicity in the colon of Fischer 344 rats</article-title><source><italic toggle="yes">Biochemical and Biophysical Research Communications</italic></source><year>2015</year><volume>461</volume><issue>2</issue><fpage>314</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2015.04.030</pub-id><pub-id pub-id-type="other">2-s2.0-84937762726</pub-id><?supplied-pmid 25881504?><pub-id pub-id-type="pmid">25881504</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marques</surname><given-names>F. M.</given-names></name><name><surname>Figueira</surname><given-names>M. M.</given-names></name><name><surname>Schmitt</surname><given-names>E. F. P.</given-names></name><etal/></person-group><article-title>In vitro anti-inflammatory activity of terpenes via suppression of superoxide and nitric oxide generation and the NF-<italic>&#x003ba;</italic>B signalling pathway</article-title><source><italic toggle="yes">Inflammopharmacology</italic></source><year>2018</year><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/s10787-018-0483-z</pub-id><pub-id pub-id-type="other">2-s2.0-85045743614</pub-id><pub-id pub-id-type="pmid">29110118</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pivetta</surname><given-names>T. P.</given-names></name><name><surname>Sim&#x000f5;es</surname><given-names>S.</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>M. M.</given-names></name><name><surname>Carvalho</surname><given-names>T.</given-names></name><name><surname>Arruda</surname><given-names>C.</given-names></name><name><surname>Marcato</surname><given-names>P. D.</given-names></name></person-group><article-title>Development of nanoparticles from natural lipids for topical delivery of thymol: investigation of its anti-inflammatory properties</article-title><source><italic toggle="yes">Colloids and Surfaces B: Biointerfaces</italic></source><year>2018</year><volume>164</volume><fpage>281</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2018.01.053</pub-id><pub-id pub-id-type="other">2-s2.0-85041409969</pub-id><?supplied-pmid 29413607?><pub-id pub-id-type="pmid">29413607</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>D. H. S.</given-names></name><name><surname>Castro-Gamboa</surname><given-names>I.</given-names></name><name><surname>Bolzani</surname><given-names>V. D. S.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Verpoorte</surname><given-names>R.</given-names></name></person-group><article-title>Plant diversity from Brazilian Cerrado and Atlantic Forest as a tool for prospecting potential therapeutic drugs</article-title><source><italic toggle="yes">Comprehensive Natural Products II Chemistry and Biology, Vol. 3</italic></source><year>2010</year><publisher-loc>Oxford, UK</publisher-loc><publisher-name>Elsevier</publisher-name><fpage>95</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/B978-008045382-8.00061-7</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>A. L.</given-names></name><name><surname>Edrada-Ebel</surname><given-names>R.</given-names></name><name><surname>Quinn</surname><given-names>R. J.</given-names></name></person-group><article-title>The re-emergence of natural products for drug discovery in the genomics era</article-title><source><italic toggle="yes">Nature Reviews Drug Discovery</italic></source><year>2015</year><volume>14</volume><issue>2</issue><fpage>111</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1038/nrd4510</pub-id><pub-id pub-id-type="other">2-s2.0-84926205808</pub-id><?supplied-pmid 25614221?><pub-id pub-id-type="pmid">25614221</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheridan</surname><given-names>C.</given-names></name></person-group><article-title>Recasting natural product research</article-title><source><italic toggle="yes">Nature Biotechnology</italic></source><year>2012</year><volume>30</volume><issue>5</issue><fpage>385</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1038/nbt.2208</pub-id><pub-id pub-id-type="other">2-s2.0-84865674915</pub-id><?supplied-pmid 22565956?><pub-id pub-id-type="pmid">22565956</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balachandran</surname><given-names>P.</given-names></name><name><surname>Govindarajan</surname><given-names>R.</given-names></name></person-group><article-title>Ayurvedic drug discovery</article-title><source><italic toggle="yes">Expert Opinion on Drug Discovery</italic></source><year>2007</year><volume>2</volume><issue>12</issue><fpage>1631</fpage><lpage>1652</lpage><pub-id pub-id-type="doi">10.1517/17460441.2.12.1631</pub-id><pub-id pub-id-type="other">2-s2.0-37349021702</pub-id><?supplied-pmid 23488906?><pub-id pub-id-type="pmid">23488906</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>W. Y.</given-names></name><name><surname>Hou</surname><given-names>J. J.</given-names></name><name><surname>Long</surname><given-names>H. L.</given-names></name><name><surname>Yang</surname><given-names>W. Z.</given-names></name><name><surname>Liang</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>D. A.</given-names></name></person-group><article-title>TCM-based new drug discovery and development in China</article-title><source><italic toggle="yes">Chinese Journal of Natural Medicines</italic></source><year>2014</year><volume>12</volume><issue>4</issue><fpage>241</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1016/S1875-5364(14)60050-9</pub-id><pub-id pub-id-type="other">2-s2.0-84901332939</pub-id><?supplied-pmid 24863348?><pub-id pub-id-type="pmid">24863348</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Aguilar-Nascimento</surname><given-names>J. E.</given-names></name></person-group><article-title>Fundamental steps in experimental design for animal studies</article-title><source><italic toggle="yes">Acta Cirurgica Brasileira</italic></source><year>2005</year><volume>20</volume><issue>1</issue><fpage>2</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1590/S0102-86502005000100002</pub-id><?supplied-pmid 15810459?><pub-id pub-id-type="pmid">15810459</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirst</surname><given-names>J. A.</given-names></name><name><surname>Howick</surname><given-names>J.</given-names></name><name><surname>Aronson</surname><given-names>J. K.</given-names></name><etal/></person-group><article-title>The need for randomization in animal trials: an overview of systematic reviews</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2014</year><volume>9</volume><issue>6, article e98856</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0098856</pub-id><pub-id pub-id-type="other">2-s2.0-84902597896</pub-id><?supplied-pmid 24906117?><pub-id pub-id-type="pmid">24906117</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medzhitov</surname><given-names>R.</given-names></name><name><surname>Janeway</surname><given-names>C. A.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Innate immunity: the virtues of a nonclonal system of recognition</article-title><source><italic toggle="yes">Cell</italic></source><year>1997</year><volume>91</volume><issue>3</issue><fpage>295</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80412-2</pub-id><pub-id pub-id-type="other">2-s2.0-0030666222</pub-id><?supplied-pmid 9363937?><pub-id pub-id-type="pmid">9363937</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujiwara</surname><given-names>N.</given-names></name><name><surname>Kobayashi</surname><given-names>K.</given-names></name></person-group><article-title>Macrophages in inflammation</article-title><source><italic toggle="yes">Current Drug Targets - Inflammation &#x00026; Allergy</italic></source><year>2005</year><volume>4</volume><issue>3</issue><fpage>281</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.2174/1568010054022024</pub-id><pub-id pub-id-type="other">2-s2.0-21044449439</pub-id><pub-id pub-id-type="pmid">16101534</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ariel</surname><given-names>A.</given-names></name><name><surname>Serhan</surname><given-names>C. N.</given-names></name></person-group><article-title>New lives given by cell death: macrophage differentiation following their encounter with apoptotic leukocytes during the resolution of inflammation</article-title><source><italic toggle="yes">Frontiers in Immunology</italic></source><year>2012</year><volume>3</volume><pub-id pub-id-type="doi">10.3389/fimmu.2012.00004</pub-id><pub-id pub-id-type="other">2-s2.0-84865435543</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>U.</given-names></name><name><surname>Tabibian</surname><given-names>J.</given-names></name><name><surname>Venugopal</surname><given-names>S. K.</given-names></name><name><surname>Devaraj</surname><given-names>S.</given-names></name><name><surname>Jialal</surname><given-names>I.</given-names></name></person-group><article-title>Development of an in vitro screening assay to test the antiinflammatory properties of dietary supplements and pharmacologic agents</article-title><source><italic toggle="yes">Clinical Chemistry</italic></source><year>2005</year><volume>51</volume><issue>12</issue><fpage>2252</fpage><lpage>2256</lpage><pub-id pub-id-type="doi">10.1373/clinchem.2005.056093</pub-id><pub-id pub-id-type="other">2-s2.0-28044446082</pub-id><?supplied-pmid 16166164?><pub-id pub-id-type="pmid">16166164</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esser</surname><given-names>N.</given-names></name><name><surname>Paquot</surname><given-names>N.</given-names></name><name><surname>Scheen</surname><given-names>A. J.</given-names></name></person-group><article-title>Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease</article-title><source><italic toggle="yes">Expert Opinion on Investigational Drugs</italic></source><year>2015</year><volume>24</volume><issue>3</issue><fpage>283</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1517/13543784.2015.974804</pub-id><pub-id pub-id-type="other">2-s2.0-84923037808</pub-id><?supplied-pmid 25345753?><pub-id pub-id-type="pmid">25345753</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epelman</surname><given-names>S.</given-names></name><name><surname>Lavine</surname><given-names>K. J.</given-names></name><name><surname>Randolph</surname><given-names>G. J.</given-names></name></person-group><article-title>Origin and functions of tissue macrophages</article-title><source><italic toggle="yes">Immunity</italic></source><year>2014</year><volume>41</volume><issue>1</issue><fpage>21</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2014.06.013</pub-id><pub-id pub-id-type="other">2-s2.0-84904401883</pub-id><?supplied-pmid 25035951?><pub-id pub-id-type="pmid">25035951</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nathan</surname><given-names>C.</given-names></name><name><surname>Ding</surname><given-names>A.</given-names></name></person-group><article-title>Nonresolving inflammation</article-title><source><italic toggle="yes">Cell</italic></source><year>2010</year><volume>140</volume><issue>6</issue><fpage>871</fpage><lpage>882</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.02.029</pub-id><pub-id pub-id-type="other">2-s2.0-77950365906</pub-id><?supplied-pmid 20303877?><pub-id pub-id-type="pmid">20303877</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murakami</surname><given-names>M.</given-names></name><name><surname>Hirano</surname><given-names>T.</given-names></name></person-group><article-title>The molecular mechanisms of chronic inflammation development</article-title><source><italic toggle="yes">Frontiers in Immunology</italic></source><year>2012</year><volume>3</volume><pub-id pub-id-type="doi">10.3389/fimmu.2012.00323</pub-id><pub-id pub-id-type="other">2-s2.0-84874205443</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huseby</surname><given-names>E. S.</given-names></name><name><surname>Huseby</surname><given-names>P. G.</given-names></name><name><surname>Shah</surname><given-names>S.</given-names></name><name><surname>Smith</surname><given-names>R.</given-names></name><name><surname>Stadinski</surname><given-names>B. D.</given-names></name></person-group><article-title>Pathogenic CD8 T cells in multiple sclerosis and its experimental models</article-title><source><italic toggle="yes">Frontiers in Immunology</italic></source><year>2012</year><volume>3</volume><pub-id pub-id-type="doi">10.3389/fimmu.2012.00064</pub-id><pub-id pub-id-type="other">2-s2.0-84874139422</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>H.</given-names></name><name><surname>Chun</surname><given-names>J.</given-names></name><name><surname>Jung</surname><given-names>H.</given-names></name><name><surname>Choi</surname><given-names>C.</given-names></name><name><surname>Bae</surname><given-names>Y.</given-names></name></person-group><article-title>Role of NADPH oxidase 4 in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells</article-title><source><italic toggle="yes">Cardiovascular Research</italic></source><year>2006</year><volume>72</volume><issue>3</issue><fpage>447</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2006.09.012</pub-id><pub-id pub-id-type="other">2-s2.0-33750519444</pub-id><?supplied-pmid 17064675?><pub-id pub-id-type="pmid">17064675</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakai</surname><given-names>J.</given-names></name><name><surname>Cammarota</surname><given-names>E.</given-names></name><name><surname>Wright</surname><given-names>J. A.</given-names></name><etal/></person-group><article-title>Lipopolysaccharide-induced NF-<italic>&#x003ba;</italic>B nuclear translocation is primarily dependent on MyD88, but TNF<italic>&#x003b1;</italic> expression requires TRIF and MyD88</article-title><source><italic toggle="yes">Scientific Reports</italic></source><year>2017</year><volume>7</volume><issue>1</issue><fpage>p. 1428</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-01600-y</pub-id><pub-id pub-id-type="other">2-s2.0-85018761913</pub-id><?supplied-pmid 28469251?><pub-id pub-id-type="pmid">28469251</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinarello</surname><given-names>C. A.</given-names></name></person-group><article-title>A clinical perspective of IL-1<italic>&#x003b2;</italic> as the gatekeeper of inflammation</article-title><source><italic toggle="yes">European Journal of Immunology</italic></source><year>2011</year><volume>41</volume><issue>5</issue><fpage>1203</fpage><lpage>1217</lpage><pub-id pub-id-type="doi">10.1002/eji.201141550</pub-id><pub-id pub-id-type="other">2-s2.0-79955148909</pub-id><?supplied-pmid 21523780?><pub-id pub-id-type="pmid">21523780</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>G. P.</given-names></name><name><surname>Beck</surname><given-names>P. L.</given-names></name><name><surname>Herridge</surname><given-names>M. S.</given-names></name><name><surname>Depew</surname><given-names>W. T.</given-names></name><name><surname>Szewczuk</surname><given-names>M. R.</given-names></name><name><surname>Wallace</surname><given-names>J. L.</given-names></name></person-group><article-title>Hapten-induced model of chronic inflammation and ulceration in the rat colon</article-title><source><italic toggle="yes">Gastroenterology</italic></source><year>1989</year><volume>96</volume><issue>3</issue><fpage>795</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1016/0016-5085(89)90904-9</pub-id><pub-id pub-id-type="other">2-s2.0-85034894992</pub-id><?supplied-pmid 2914642?><pub-id pub-id-type="pmid">2914642</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>A.</given-names></name><name><surname>Fukui</surname><given-names>H.</given-names></name><name><surname>Fujii</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Role of Necl-5 in the pathophysiology of colorectal lesions induced by dimethylhydrazine and/or dextran sodium sulphate</article-title><source><italic toggle="yes">Journal of Pathology</italic></source><year>2009</year><volume>217</volume><issue>1</issue><fpage>42</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1002/path.2431</pub-id><pub-id pub-id-type="other">2-s2.0-58449124887</pub-id><?supplied-pmid 18973187?><pub-id pub-id-type="pmid">18973187</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizuno</surname><given-names>Y.</given-names></name><name><surname>Jacob</surname><given-names>R. F.</given-names></name><name><surname>Mason</surname><given-names>R. P.</given-names></name></person-group><article-title>Inflammation and the development of atherosclerosis</article-title><source><italic toggle="yes">Journal of Atherosclerosis and Thrombosis</italic></source><year>2011</year><volume>18</volume><issue>5</issue><fpage>351</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.5551/jat.7591</pub-id><pub-id pub-id-type="other">2-s2.0-79958032424</pub-id><?supplied-pmid 21427505?><pub-id pub-id-type="pmid">21427505</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Libby</surname><given-names>P.</given-names></name></person-group><article-title>Inflammation in atherosclerosis</article-title><source><italic toggle="yes">Arteriosclerosis, Thrombosis, and Vascular Biology</italic></source><year>2012</year><volume>32</volume><issue>9</issue><fpage>2045</fpage><lpage>2051</lpage><pub-id pub-id-type="doi">10.1161/ATVBAHA.108.179705</pub-id><pub-id pub-id-type="other">2-s2.0-84865485915</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>B. W.</given-names></name><name><surname>Meredith</surname><given-names>A.</given-names></name><name><surname>Lin</surname><given-names>D.</given-names></name><name><surname>McManus</surname><given-names>B. M.</given-names></name></person-group><article-title>The biological role of inflammation in atherosclerosis</article-title><source><italic toggle="yes">Canadian Journal of Cardiology</italic></source><year>2012</year><volume>28</volume><issue>6</issue><fpage>631</fpage><lpage>641</lpage><pub-id pub-id-type="doi">10.1016/j.cjca.2012.06.023</pub-id><pub-id pub-id-type="other">2-s2.0-84869095071</pub-id><?supplied-pmid 22985787?><pub-id pub-id-type="pmid">22985787</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunskaar</surname><given-names>S.</given-names></name><name><surname>Hole</surname><given-names>K.</given-names></name></person-group><article-title>The formalin test in mice: dissociation between inflammatory and non-inflammatory pain</article-title><source><italic toggle="yes">Pain</italic></source><year>1987</year><volume>30</volume><issue>1</issue><fpage>103</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/0304-3959(87)90088-1</pub-id><pub-id pub-id-type="other">2-s2.0-0023223448</pub-id><?supplied-pmid 3614974?><pub-id pub-id-type="pmid">3614974</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>M. A.</given-names></name><name><surname>de Castro Bastos</surname><given-names>L.</given-names></name><name><surname>Tonussi</surname><given-names>C. R.</given-names></name></person-group><article-title>Formalin injection into knee joints of rats: pharmacologic characterization of a deep somatic nociceptive model</article-title><source><italic toggle="yes">The Journal of Pain</italic></source><year>2006</year><volume>7</volume><issue>2</issue><fpage>100</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.jpain.2005.09.002</pub-id><pub-id pub-id-type="other">2-s2.0-32044447504</pub-id><?supplied-pmid 16459275?><pub-id pub-id-type="pmid">16459275</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukhopadhyay</surname><given-names>S.</given-names></name><name><surname>Wilcox</surname><given-names>B. E.</given-names></name><name><surname>Myers</surname><given-names>J. L.</given-names></name><etal/></person-group><article-title>Pulmonary necrotizing granulomas of unknown cause: clinical and pathologic analysis of 131 patients with completely resected nodules</article-title><source><italic toggle="yes">Chest</italic></source><year>2013</year><volume>144</volume><issue>3</issue><fpage>813</fpage><lpage>824</lpage><pub-id pub-id-type="doi">10.1378/chest.12-2113</pub-id><pub-id pub-id-type="other">2-s2.0-84884333082</pub-id><?supplied-pmid 23558582?><pub-id pub-id-type="pmid">23558582</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>K. K.</given-names></name><name><surname>Pritt</surname><given-names>B. S.</given-names></name><name><surname>Alexander</surname><given-names>M. P.</given-names></name></person-group><article-title>Histopathologic review of granulomatous inflammation</article-title><source><italic toggle="yes">Journal of Clinical Tuberculosis and Other Mycobacterial Diseases</italic></source><year>2017</year><volume>7</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.jctube.2017.02.001</pub-id><pub-id pub-id-type="other">2-s2.0-85013271887</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poyton</surname><given-names>R. O.</given-names></name><name><surname>Ball</surname><given-names>K. A.</given-names></name><name><surname>Castello</surname><given-names>P. R.</given-names></name></person-group><article-title>Mitochondrial generation of free radicals and hypoxic signaling</article-title><source><italic toggle="yes">Trends in Endocrinology and Metabolism</italic></source><year>2009</year><volume>20</volume><issue>7</issue><fpage>332</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2009.04.001</pub-id><pub-id pub-id-type="other">2-s2.0-69849097192</pub-id><?supplied-pmid 19733481?><pub-id pub-id-type="pmid">19733481</pub-id></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arulselvan</surname><given-names>P.</given-names></name><name><surname>Fard</surname><given-names>M. T.</given-names></name><name><surname>Tan</surname><given-names>W. S.</given-names></name><etal/></person-group><article-title>Role of antioxidants and natural products in inflammation</article-title><source><italic toggle="yes">Oxidative Medicine and Cellular Longevity</italic></source><year>2016</year><volume>2016</volume><fpage>15</fpage><pub-id pub-id-type="doi">10.1155/2016/5276130</pub-id><pub-id pub-id-type="other">2-s2.0-84994037380</pub-id><pub-id pub-id-type="publisher-id">5276130</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>K. H.</given-names></name><name><surname>Hashimoto</surname><given-names>N.</given-names></name><name><surname>Fukushima</surname><given-names>M.</given-names></name></person-group><article-title>Relationships among alcoholic liver disease, antioxidants, and antioxidant enzymes</article-title><source><italic toggle="yes">World Journal of Gastroenterology</italic></source><year>2016</year><volume>22</volume><issue>1</issue><fpage>37</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.3748/wjg.v22.i1.37</pub-id><pub-id pub-id-type="other">2-s2.0-84953375435</pub-id><?supplied-pmid 26755859?><pub-id pub-id-type="pmid">26755859</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aslani</surname><given-names>B. A.</given-names></name><name><surname>Ghobadi</surname><given-names>S.</given-names></name></person-group><article-title>Studies on oxidants and antioxidants with a brief glance at their relevance to the immune system</article-title><source><italic toggle="yes">Life Sciences</italic></source><year>2016</year><volume>146</volume><fpage>163</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2016.01.014</pub-id><pub-id pub-id-type="other">2-s2.0-84955154004</pub-id><?supplied-pmid 26792059?><pub-id pub-id-type="pmid">26792059</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Xia</surname><given-names>M. X.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Yuan</surname><given-names>R.</given-names></name><name><surname>Deng</surname><given-names>F. N.</given-names></name><name><surname>Shen</surname><given-names>F. F.</given-names></name></person-group><article-title>Gene expression characteristics and regulation mechanisms of superoxide dismutase and its physiological roles in plants under stress</article-title><source><italic toggle="yes">Biochemistry</italic></source><year>2016</year><volume>81</volume><issue>5</issue><fpage>465</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1134/S0006297916050047</pub-id><pub-id pub-id-type="other">2-s2.0-84969771455</pub-id><?supplied-pmid 27297897?><pub-id pub-id-type="pmid">27297897</pub-id></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>B. H.</given-names></name><name><surname>Shi</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Glutathione peroxidase level in patients with vitiligo: a meta-analysis</article-title><source><italic toggle="yes">BioMed Research International</italic></source><year>2016</year><volume>2016</volume><fpage>11</fpage><pub-id pub-id-type="doi">10.1155/2016/3029810</pub-id><pub-id pub-id-type="other">2-s2.0-84973333131</pub-id><pub-id pub-id-type="publisher-id">3029810</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anju</surname><given-names>A.</given-names></name><name><surname>Jeswin</surname><given-names>J.</given-names></name><name><surname>Thomas</surname><given-names>P. C.</given-names></name><name><surname>Paulton</surname><given-names>M. P.</given-names></name><name><surname>Vijayan</surname><given-names>K. K.</given-names></name></person-group><article-title>Molecular cloning, characterization and expression analysis of cytoplasmic Cu/Zn-superoxid dismutase (SOD) from pearl oyster <italic>Pinctada fucata</italic></article-title><source><italic toggle="yes">Fish &#x00026; Shellfish Immunology</italic></source><year>2013</year><volume>34</volume><issue>3</issue><fpage>946</fpage><lpage>950</lpage><pub-id pub-id-type="doi">10.1016/j.fsi.2012.12.024</pub-id><pub-id pub-id-type="other">2-s2.0-84880670126</pub-id><?supplied-pmid 23318997?><pub-id pub-id-type="pmid">23318997</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valko</surname><given-names>M.</given-names></name><name><surname>Rhodes</surname><given-names>C. J.</given-names></name><name><surname>Moncol</surname><given-names>J.</given-names></name><name><surname>Izakovic</surname><given-names>M.</given-names></name><name><surname>Mazur</surname><given-names>M.</given-names></name></person-group><article-title>Free radicals, metals and antioxidants in oxidative stress-induced cancer</article-title><source><italic toggle="yes">Chemico-Biological Interactions</italic></source><year>2006</year><volume>160</volume><issue>1</issue><fpage>1</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2005.12.009</pub-id><pub-id pub-id-type="other">2-s2.0-32444433202</pub-id><?supplied-pmid 16430879?><pub-id pub-id-type="pmid">16430879</pub-id></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baser</surname><given-names>K. C.</given-names></name></person-group><article-title>Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils</article-title><source><italic toggle="yes">Current Pharmaceutical Design</italic></source><year>2008</year><volume>14</volume><issue>29</issue><fpage>3106</fpage><lpage>3119</lpage><pub-id pub-id-type="doi">10.2174/138161208786404227</pub-id><pub-id pub-id-type="other">2-s2.0-58849121486</pub-id><?supplied-pmid 19075694?><pub-id pub-id-type="pmid">19075694</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guimar&#x000e3;es</surname><given-names>A. G.</given-names></name><name><surname>Oliveira</surname><given-names>G. F.</given-names></name><name><surname>Melo</surname><given-names>M. S.</given-names></name><etal/></person-group><article-title>Bioassay-guided evaluation of antioxidant and antinociceptive activities of carvacrol</article-title><source><italic toggle="yes">Basic &#x00026; Clinical Pharmacology &#x00026; Toxicology</italic></source><year>2010</year><volume>107</volume><issue>6</issue><fpage>949</fpage><lpage>957</lpage><pub-id pub-id-type="doi">10.1111/j.1742-7843.2010.00609.x</pub-id><pub-id pub-id-type="other">2-s2.0-78649577588</pub-id><?supplied-pmid 20849525?><pub-id pub-id-type="pmid">20849525</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freire</surname><given-names>R. S.</given-names></name><name><surname>Morais</surname><given-names>S. M.</given-names></name><name><surname>Catunda-Junior</surname><given-names>F. E. A.</given-names></name><name><surname>Pinheiro</surname><given-names>D. C. S. N.</given-names></name></person-group><article-title>Synthesis and antioxidant, anti-inflammatory and gastroprotector activities of anethole and related compounds</article-title><source><italic toggle="yes">Bioorganic &#x00026; Medicinal Chemistry</italic></source><year>2005</year><volume>13</volume><issue>13</issue><fpage>4353</fpage><lpage>4358</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2005.03.058</pub-id><pub-id pub-id-type="other">2-s2.0-20344379930</pub-id><?supplied-pmid 15890516?><pub-id pub-id-type="pmid">15890516</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosalec</surname><given-names>I.</given-names></name><name><surname>Pepeljnjak</surname><given-names>S.</given-names></name><name><surname>Kustrak</surname><given-names>D.</given-names></name></person-group><article-title>Antifungal activity of fluid extract and essential oil from anise fruits (<italic>Pimpinella anisum</italic> L., <italic>Apiaceae</italic>)</article-title><source><italic toggle="yes">Acta Pharmaceutica</italic></source><year>2005</year><volume>55</volume><issue>4</issue><fpage>377</fpage><lpage>385</lpage><?supplied-pmid 16375827?><pub-id pub-id-type="pmid">16375827</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huo</surname><given-names>M.</given-names></name><name><surname>Cui</surname><given-names>X.</given-names></name><name><surname>Xue</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Anti-inflammatory effects of linalool in RAW 264.7 macrophages and lipopolysaccharide-induced lung injury model</article-title><source><italic toggle="yes">Journal of Surgical Research</italic></source><year>2013</year><volume>180</volume><issue>1</issue><fpage>e47</fpage><lpage>e54</lpage><pub-id pub-id-type="doi">10.1016/j.jss.2012.10.050</pub-id><pub-id pub-id-type="other">2-s2.0-84873703229</pub-id><?supplied-pmid 23228323?><pub-id pub-id-type="pmid">23228323</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendes</surname><given-names>S. J. F.</given-names></name><name><surname>Sousa</surname><given-names>F. I. A. B.</given-names></name><name><surname>Pereira</surname><given-names>D. M. S.</given-names></name><etal/></person-group><article-title>Cinnamaldehyde modulates LPS-induced systemic inflammatory response syndrome through TRPA1-dependent and independent mechanisms</article-title><source><italic toggle="yes">International Immunopharmacology</italic></source><year>2016</year><volume>34</volume><fpage>60</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2016.02.012</pub-id><pub-id pub-id-type="other">2-s2.0-84959093301</pub-id><?supplied-pmid 26922677?><pub-id pub-id-type="pmid">26922677</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>D.</given-names></name><name><surname>Griendling</surname><given-names>K. K.</given-names></name><name><surname>Landmesser</surname><given-names>U.</given-names></name><name><surname>Hornig</surname><given-names>B.</given-names></name><name><surname>Drexler</surname><given-names>H.</given-names></name></person-group><article-title>Role of oxidative stress in atherosclerosis</article-title><source><italic toggle="yes">The American Journal of Cardiology</italic></source><year>2003</year><volume>91</volume><issue>3</issue><fpage>7</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/S0002-9149(02)03144-2</pub-id><pub-id pub-id-type="other">2-s2.0-0037421492</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Flowchart detailing literature searching and screening.</p></caption><graphic xlink:href="OMCL2018-6468593.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Distribution of the selected studies by country (a) and year of publication (b).</p></caption><graphic xlink:href="OMCL2018-6468593.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Methodological quality of included <italic>in vivo</italic> studies. White bars indicate the proportion of articles that met each criterion; black bars indicate the proportion of studies that did not, and gray bars indicate the proportion of studies with unclear answers.</p></caption><graphic xlink:href="OMCL2018-6468593.003"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Chemical structure of the major constituents of the essential oils evaluated as antioxidant and anti-inflammatory in chronic inflammation.</p></caption><graphic xlink:href="OMCL2018-6468593.004"/></fig><fig id="fig5" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Chemical structure of the constituents isolated of the essential oils evaluated as antioxidant and anti-inflammatory in chronic inflammation.</p></caption><graphic xlink:href="OMCL2018-6468593.005"/></fig><fig id="fig6" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Molecular mechanisms of action of essential oils activity mediating signaling involving inhibition of NF-<italic>&#x003ba;</italic>B, MAPK, and decreased intracellular oxidative stress.</p></caption><graphic xlink:href="OMCL2018-6468593.006"/></fig><table-wrap id="tab1" content-type="sidewaystable" orientation="portrait" position="float"><label>Table 1</label><caption><p>General characteristics of included studies (<italic>in vitro</italic> and <italic>in vivo</italic> reports).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Authors, year, country</th><th align="center" rowspan="1" colspan="1">Model</th><th align="center" rowspan="1" colspan="1">Essential oil</th><th align="center" rowspan="1" colspan="1">Major constituents</th><th align="center" rowspan="1" colspan="1">Family</th><th align="center" rowspan="1" colspan="1">Induction of inflammation</th><th align="center" rowspan="1" colspan="1">Type of inflammation</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Tsai et al., 2011, Taiwan [<xref rid="B24" ref-type="bibr">24</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vitro</italic></td><td align="center" rowspan="1" colspan="1">Essential oils of the aerial parts of <italic>Eucalyptus bridgesiana</italic>, <italic>Cymbopogon martinii</italic>, <italic>Thymus vulgaris</italic>, <italic>Lindernia anagallis</italic>, and <italic>Pelargonium fragrans</italic></td><td align="center" rowspan="1" colspan="1">1,8-Cineole<break/>Geraniol<break/>Thymol<break/><italic>p</italic>-Menthanone<break/>(&#x02212;)-Spathulenol</td><td align="center" rowspan="1" colspan="1">Myrtaceae<break/>Poaceae<break/>Lamiaceae<break/>Linderniaceae<break/>Geraniaceae</td><td align="center" rowspan="1" colspan="1">Lipopolysaccharide (LPS) from <italic>Escherichia coli</italic> and heat-killed <italic>Propionibacterium acnes</italic></td><td align="center" rowspan="1" colspan="1">Inflammation induced by biological agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Ritter et al., 2013, Brazil [<xref rid="B25" ref-type="bibr">25</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vivo</italic></td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">Anethole</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">Complete Freund's adjuvant</td><td align="center" rowspan="1" colspan="1">Inflammation induced by biological agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Jeena et al., 2013, India [<xref rid="B26" ref-type="bibr">26</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vivo</italic></td><td align="center" rowspan="1" colspan="1">Essential oil of ginger</td><td align="center" rowspan="1" colspan="1">Zingiberene</td><td align="center" rowspan="1" colspan="1">Zingiberaceae</td><td align="center" rowspan="1" colspan="1">Formalin</td><td align="center" rowspan="1" colspan="1">Inflammation induced by chemical agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">El-Readi et al., 2013, Egypt [<xref rid="B27" ref-type="bibr">27</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vitro</italic></td><td align="center" rowspan="1" colspan="1">Essential oils from leaves and stems of <italic>Liquidambar styraciflua</italic></td><td align="center" rowspan="1" colspan="1"><italic>&#x003b1;</italic>-Pinene</td><td align="center" rowspan="1" colspan="1">Altingiaceae</td><td align="center" rowspan="1" colspan="1">LPS from <italic>Escherichia coli</italic></td><td align="center" rowspan="1" colspan="1">Inflammation induced by biological agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Valente et al. 2013, Portugal [<xref rid="B28" ref-type="bibr">28</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vitro</italic></td><td align="center" rowspan="1" colspan="1">Essential oils of the aerial parts of <italic>Oenanthe crocata L.</italic></td><td align="center" rowspan="1" colspan="1"><italic>&#x003b2;-</italic>Ocimene<break/>Sabinene</td><td align="center" rowspan="1" colspan="1">Apiaceae</td><td align="center" rowspan="1" colspan="1">LPS from <italic>Escherichia coli</italic> and INF-<italic>&#x003b3;</italic></td><td align="center" rowspan="1" colspan="1">Inflammation induced by biological agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Lin et al., 2014, China [<xref rid="B29" ref-type="bibr">29</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vitro</italic></td><td align="center" rowspan="1" colspan="1">Essential oil of <italic>Patrinia scabiosaefolia</italic></td><td align="center" rowspan="1" colspan="1">Caryophyllene oxide</td><td align="center" rowspan="1" colspan="1">Caprifoliaceae</td><td align="center" rowspan="1" colspan="1">LPS from <italic>Escherichia coli</italic></td><td align="center" rowspan="1" colspan="1">Inflammation induced by biological agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Destryana et al., 2014, Indonesia [<xref rid="B30" ref-type="bibr">30</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vitro</italic></td><td align="center" rowspan="1" colspan="1">Essential oil from leaf and branches of <italic>Ocotea quixos</italic>, wood, branches, and leaves of <italic>Callitris intratropica</italic> and <italic>Copaifera reticulata/langsdorffii</italic> gum-resin</td><td align="center" rowspan="1" colspan="1"><italic>trans</italic>-Caryophyllene<break/><italic>&#x003b2;</italic>-Caryophyllene<break/>(+)-Calarene</td><td align="center" rowspan="1" colspan="1">Lauraceae<break/>Cupressaceae<break/>Fabaceae</td><td align="center" rowspan="1" colspan="1">LPS from <italic>Escherichia coli</italic></td><td align="center" rowspan="1" colspan="1">Inflammation induced by biological agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Shirole et al., 2014, India [<xref rid="B31" ref-type="bibr">31</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vitro</italic> and <italic>in vivo</italic></td><td align="center" rowspan="1" colspan="1">Essential oil of <italic>Pistacia integerrima</italic></td><td align="center" rowspan="1" colspan="1">4-Carvomenthenol</td><td align="center" rowspan="1" colspan="1">Anacardiaceae</td><td align="center" rowspan="1" colspan="1">LPS from <italic>Escherichia coli</italic> and ovalbumin</td><td align="center" rowspan="1" colspan="1">Inflammation induced by biological agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Patil et al. 2014, India [<xref rid="B32" ref-type="bibr">32</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vivo</italic></td><td align="center" rowspan="1" colspan="1">Essential oil of <italic>Camellia reticulata</italic> L.</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">Theaceae</td><td align="center" rowspan="1" colspan="1">Indomethacin</td><td align="center" rowspan="1" colspan="1">Inflammation induced by chemical agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Khodabakhsh et al. 2014, Japan [<xref rid="B33" ref-type="bibr">33</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vivo</italic></td><td align="center" rowspan="1" colspan="1">Essential oil from blossoms of <italic>Citrus aurantium</italic> L.</td><td align="center" rowspan="1" colspan="1">Linalool</td><td align="center" rowspan="1" colspan="1">Rutaceae</td><td align="center" rowspan="1" colspan="1">Cotton pellet&#x02014;subcutaneous</td><td align="center" rowspan="1" colspan="1">Inflammation induced by physical agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Wu et al., 2014, China [<xref rid="B34" ref-type="bibr">34</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vivo</italic></td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">Linalool</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1"><italic>Pasteurella multocida</italic> intranasal</td><td align="center" rowspan="1" colspan="1">Inflammation induced by biological agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Jeena et al., 2014, India [<xref rid="B35" ref-type="bibr">35</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vivo</italic></td><td align="center" rowspan="1" colspan="1">Essential oil of <italic>Piper nigrum</italic> Linn</td><td align="center" rowspan="1" colspan="1">Caryophyllene</td><td align="center" rowspan="1" colspan="1">Piperaceae</td><td align="center" rowspan="1" colspan="1">Formalin</td><td align="center" rowspan="1" colspan="1">Inflammation induced by chemical agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Entok et al., 2014, Turkey [<xref rid="B36" ref-type="bibr">36</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vivo</italic></td><td align="center" rowspan="1" colspan="1">Essential oil of <italic>Nigella sativa</italic> L.</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">Ranunculaceae</td><td align="center" rowspan="1" colspan="1">LPS from <italic>Escherichia coli</italic></td><td align="center" rowspan="1" colspan="1">Inflammation induced by biological agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Kazemi 2015, Iran [<xref rid="B37" ref-type="bibr">37</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vitro</italic></td><td align="center" rowspan="1" colspan="1">Essential oils <italic>of Achillea millefolium</italic> L., <italic>Anethum graveolens</italic> L., and <italic>Carum copticum</italic> L.</td><td align="center" rowspan="1" colspan="1">Thymol</td><td align="center" rowspan="1" colspan="1">Asteraceae<break/>Apiaceae</td><td align="center" rowspan="1" colspan="1">LPS from <italic>Escherichia coli</italic></td><td align="center" rowspan="1" colspan="1">Inflammation induced by biological agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Pinheiro et al., 2015, Brazil [<xref rid="B38" ref-type="bibr">38</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vivo</italic></td><td align="center" rowspan="1" colspan="1">Essential oil from leaves of <italic>Choisya ternata</italic> Kunth</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">Rutaceae</td><td align="center" rowspan="1" colspan="1">Dorsal subcutaneous injection of sterile air and carrageenan suspension</td><td align="center" rowspan="1" colspan="1">Inflammation induced by chemical agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Kara et al. 2015, Turkey [<xref rid="B39" ref-type="bibr">39</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vivo</italic></td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">Carvacrol</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">LPS from <italic>Escherichia coli</italic></td><td align="center" rowspan="1" colspan="1">Inflammation induced by biological agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Allam et al. 2015, Egypt [<xref rid="B40" ref-type="bibr">40</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vivo</italic></td><td align="center" rowspan="1" colspan="1">Essential oil of thyme</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">Lamiaceae</td><td align="center" rowspan="1" colspan="1"><italic>Shigella flexneri</italic></td><td align="center" rowspan="1" colspan="1">Inflammation induced by biological agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Shen et al. 2016, China [<xref rid="B41" ref-type="bibr">41</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vitro</italic></td><td align="center" rowspan="1" colspan="1">Essential oil of calyx of <italic>Hibiscus sabdariffa L.</italic></td><td align="center" rowspan="1" colspan="1"><italic>n</italic>-Hexadecanoic acid</td><td align="center" rowspan="1" colspan="1">Malvaceae</td><td align="center" rowspan="1" colspan="1">LPS from <italic>Escherichia coli</italic></td><td align="center" rowspan="1" colspan="1">Inflammation induced by biological agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Park et al., 2016, Korea [<xref rid="B42" ref-type="bibr">42</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vitro and in vivo</italic></td><td align="center" rowspan="1" colspan="1">Essential oil of <italic>Chamaecyparis obtusa</italic></td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">Cupressaceae</td><td align="center" rowspan="1" colspan="1"><italic>In vitro</italic>: LPS from <italic>Escherichia coli</italic><break/><italic>In vivo:</italic> carrageenan-induced paw edema, thioglycollate-induced peritonitis</td><td align="center" rowspan="1" colspan="1">Inflammation induced by biological and chemical agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Skala et al., 2016, Poland [<xref rid="B43" ref-type="bibr">43</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vitro</italic></td><td align="center" rowspan="1" colspan="1">Essential oils from roots of <italic>Rhaponticum carthamoides</italic></td><td align="center" rowspan="1" colspan="1">Cyperene<break/>Aplotaxene</td><td align="center" rowspan="1" colspan="1">Asteraceae</td><td align="center" rowspan="1" colspan="1">LPS from <italic>Escherichia coli</italic></td><td align="center" rowspan="1" colspan="1">Inflammation induced by biological agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Zhao et al., 2016, China [<xref rid="B44" ref-type="bibr">44</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vivo</italic></td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">Cinnamaldehyde</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">LPS from <italic>Escherichia coli</italic></td><td align="center" rowspan="1" colspan="1">Inflammation induced by biological agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Yu et al., 2016, Brazil [<xref rid="B45" ref-type="bibr">45</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vivo</italic></td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">Thymol</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">High-fat-diet-induced hyperlipidemia and atherosclerosis.</td><td align="center" rowspan="1" colspan="1">Inflammation induced by chemical agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Kennedy-Feitosa et al. 2016, Brazil [<xref rid="B46" ref-type="bibr">46</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vivo</italic></td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">Eucalyptol</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">Exposition to commercial cigarettes</td><td align="center" rowspan="1" colspan="1">Inflammation induced by chemical agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Alvarenga et al. 2016, Brazil [<xref rid="B47" ref-type="bibr">47</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vivo</italic></td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">Carvacrol</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">Irinotecan</td><td align="center" rowspan="1" colspan="1">Inflammation induced by chemical agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Shen et al., 2017, China [<xref rid="B48" ref-type="bibr">48</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vitro</italic></td><td align="center" rowspan="1" colspan="1">Essential oil from blossoms of <italic>Citrus aurantium</italic></td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">Rutaceae</td><td align="center" rowspan="1" colspan="1">LPS from <italic>Escherichia coli</italic></td><td align="center" rowspan="1" colspan="1">Inflammation induced by biological agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Liu et al., 2017, China [<xref rid="B49" ref-type="bibr">49</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vivo</italic></td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1"><italic>&#x003b2;</italic>-Elemene</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">High-fat-diet-induced hyperlipidemia and atherosclerosis</td><td align="center" rowspan="1" colspan="1">Inflammation induced by chemical agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Leelarungrayub et al. 2017, Thailand [<xref rid="B50" ref-type="bibr">50</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vivo</italic></td><td align="center" rowspan="1" colspan="1">Essential oil of <italic>Zingiber cassumunar</italic> Roxb. in niosomes entrapped</td><td align="center" rowspan="1" colspan="1">Terpinen-4-ol</td><td align="center" rowspan="1" colspan="1">Zingiberaceae</td><td align="center" rowspan="1" colspan="1">LPS from <italic>Porphyromonas gingivalis</italic></td><td align="center" rowspan="1" colspan="1">Inflammation induced by biological agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Arigesavan and Sudhandiran 2017, India [<xref rid="B51" ref-type="bibr">51</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vivo</italic></td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">Carvacrol</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">1,2-Dimethylhydrazine (DMH) and dextran sodium sulphate (DSS)</td><td align="center" rowspan="1" colspan="1">Inflammation induced by chemical agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Marques et al., 2018, Brazil [<xref rid="B52" ref-type="bibr">52</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vitro</italic></td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">l-Carveol, l-carvone, <italic>m</italic>-cymene, valencene, and guaiene</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">LPS from <italic>Escherichia coli</italic></td><td align="center" rowspan="1" colspan="1">Inflammation induced by biological agent</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Pivetta et al. 2018, Brazil [<xref rid="B53" ref-type="bibr">53</xref>]</td><td align="center" rowspan="1" colspan="1"><italic>In vivo</italic></td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">Thymol in nanoparticles from natural lipids</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td align="center" rowspan="1" colspan="1">Imiquimod</td><td align="center" rowspan="1" colspan="1">Inflammation induced by chemical agent</td></tr></tbody></table></table-wrap><table-wrap id="tab2" content-type="sidewaystable" orientation="portrait" position="float"><label>Table 2</label><caption><p><italic>In vitro</italic> studies involving essential oils, anti-inflammatory and antioxidant activity.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Essential oil and/or majority constituent</th><th align="center" rowspan="1" colspan="1">Doses</th><th align="center" rowspan="1" colspan="1">Antioxidant and anti-inflammatory assays</th><th align="center" rowspan="1" colspan="1">Cell line</th><th align="center" rowspan="1" colspan="1">General results and proposed mechanism of action</th><th align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Essential oils of the aerial part of <italic>Eucalyptus bridgesiana</italic>, <italic>Cymbopogon martinii</italic>, <italic>Thymus vulgaris</italic>, <italic>Lindernia anagallis</italic>, and <italic>Pelargonium fragrans</italic></td><td align="center" rowspan="1" colspan="1">0.01&#x000a0;<italic>&#x003bc;</italic>g/mL</td><td align="center" rowspan="1" colspan="1"><italic>&#x003b2;</italic>-Carotene linoleic acid bleaching test, DPPH radical, and nitric oxide scavenging assay<break/>5-LOX inhibition assay<break/>Measurement of IL-1<italic>&#x003b2;</italic>, IL-8, TNF-<italic>&#x003b1;</italic></td><td align="center" rowspan="1" colspan="1">THP-1 (human mylomonocytic cell)</td><td align="center" rowspan="1" colspan="1">Strong antioxidant activity in the tests performed; inhibition of 5-LOX activity and reduction of IL-1<italic>&#x003b2;</italic>, IL-8, and TNF-<italic>&#x003b1;</italic> secretion in THP-1 cells</td><td align="center" rowspan="1" colspan="1">Tsai et al. 2011 [<xref rid="B24" ref-type="bibr">24</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Essential oils of the aerial parts of <italic>Oenanthe crocata L.</italic>, <italic>&#x003b2;-</italic>ocimene, or sabinene</td><td align="center" rowspan="1" colspan="1">EO: 0.08, 0.16, and 0.32&#x000a0;<italic>&#x003bc;</italic>L/mL<break/><italic>&#x003b2;-</italic>Ocimene and sabinene: 0.32&#x02013;1.25&#x000a0;<italic>&#x003bc;</italic>L/mL</td><td align="center" rowspan="1" colspan="1">Measurement of NO, Western blot analysis for iNOS, and nitric oxide scavenging activity</td><td align="center" rowspan="1" colspan="1">RAW 264.7 macrophages</td><td align="center" rowspan="1" colspan="1">Strong NO scavenging activity and inhibition of iNOS expression<break/>Sabinene exhibited NO scavenging activity only at higher concentrations</td><td align="center" rowspan="1" colspan="1">Valente et al. 2013 [<xref rid="B28" ref-type="bibr">28</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Essential oils from leaves and stems of <italic>Liquidambar Styraciflua</italic></td><td align="center" rowspan="1" colspan="1">1, 10, 100 and 500&#x000a0;<italic>&#x003bc;</italic>g/mL</td><td align="center" rowspan="1" colspan="1">5-LOX and PGE<sub>2</sub> inhibition<break/>DPPH radical and superoxide scavenging activity</td><td align="center" rowspan="1" colspan="1">HepG-2 cells</td><td align="center" rowspan="1" colspan="1">Reduction of DPPH, (OH<sup>&#x02022;</sup>), and (O<sub>2</sub><sup>&#x02022;</sup>) radicals<break/>Inhibition of 5-LOX and PGE<sub>2</sub></td><td align="center" rowspan="1" colspan="1">El-Readi et al. 2013 [<xref rid="B27" ref-type="bibr">27</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Essential oil of <italic>Patrinia scabiosaefolia</italic></td><td align="center" rowspan="1" colspan="1">50, 100, 150, 200, and 250&#x000a0;<italic>&#x003bc;</italic>g/mL</td><td align="center" rowspan="1" colspan="1">Measurement of IL-1 and IL-6<break/>DPPH radical scavenging assay</td><td align="center" rowspan="1" colspan="1">BV-2 cell (microglia)</td><td align="center" rowspan="1" colspan="1">Inhibition of the production of IL-1 and IL-6; scavenging activity against the DPPH radical</td><td align="center" rowspan="1" colspan="1">Jing et al. 2014 [<xref rid="B29" ref-type="bibr">29</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Essential oil from leaf and branches of <italic>Ocotea quixos</italic>, wood, and branches and leaves of <italic>Callitris intratropica</italic> and <italic>Copaifera reticulata/langsdorffii</italic> gum-resin</td><td align="center" rowspan="1" colspan="1">5, 10, an 20&#x000a0;<italic>&#x003bc;</italic>g/mL</td><td align="center" rowspan="1" colspan="1"><italic>&#x003b2;</italic>-Carotene linoleic acid bleaching test and DPPH radical scavenging assay<break/>Measurement of NO production<break/>Western blotting analyses for the iNOS and COX-2 and measurement of IL-8, IL-6, and IL-1<italic>&#x003b2;</italic></td><td align="center" rowspan="1" colspan="1">RAW 264.7 macrophages</td><td align="center" rowspan="1" colspan="1">The EO of <italic>O. quixos</italic> and <italic>C. reticulata</italic> did not possess an antioxidant activity, while Blue Cypress possessed a moderate antioxidant activity<break/>Only Ocotea suppress the LPS-induced PGE<sub>2</sub> production, LPS-mediated iNOS, and COX-2 elevation<break/>Suppression of LPS-stimulated IL-8 and IL-1<italic>&#x003b2;</italic> production in the cells</td><td align="center" rowspan="1" colspan="1">Destryana et al. 2014 [<xref rid="B30" ref-type="bibr">30</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Essential oils <italic>of Achillea millefolium</italic> L., <italic>Anethum graveolens</italic> L., and <italic>Carum copticum</italic> L.</td><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">DPPH radical scavenging and FRAP assay<break/><italic>&#x003b2;</italic>-Carotene bleaching test<break/>Determination of NO production.</td><td align="center" rowspan="1" colspan="1">RAW 264.7 macrophages</td><td align="center" rowspan="1" colspan="1"><italic>A. millefolium</italic> had the highest antioxidant activity in all conducted assays and inhibited nitric oxide production</td><td align="center" rowspan="1" colspan="1">Kazemi 2015, Iran [<xref rid="B37" ref-type="bibr">37</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Essential oil of calyx of <italic>Hibiscus sabdariffa L.</italic></td><td align="center" rowspan="1" colspan="1">25, 50, 100, 200, and 300&#x000a0;<italic>&#x003bc;</italic>g/mL</td><td align="center" rowspan="1" colspan="1">Determination of NO production<break/>Measurement of cytokines Production (IL-1 and IL-6)<break/>RT-PCR assay of IL-1, IL-6, TNF-<italic>&#x003b1;</italic>, iNOS, and COX-2 mRNA<break/>Western blot analyses for the p-JNK, p-ERK1/2, NF-<italic>&#x003ba;</italic>B, and GAPDH</td><td align="center" rowspan="1" colspan="1">RAW 264.7 macrophages</td><td align="center" rowspan="1" colspan="1">Inhibition of NF-<italic>&#x003ba;</italic>B signaling pathways and MAPK (JNK and ERK1/2), reduction of NO production and IL-1, IL-6, TNF-<italic>&#x003b1;</italic>, COX-2, and iNOS</td><td align="center" rowspan="1" colspan="1">Shen et al. 2016 [<xref rid="B41" ref-type="bibr">41</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Essential oil of <italic>Chamaecyparis obtusa</italic></td><td align="center" rowspan="1" colspan="1"><italic>In vitro</italic>: 1, 10, 50 and 100&#x000a0;<italic>&#x003bc;</italic>g/mL<break/><italic>In vivo</italic>: 5 and 10&#x02009;mg/kg</td><td align="center" rowspan="1" colspan="1"><italic>In vitro:</italic> measurement of NO, IL-1<italic>&#x003b2;</italic>, TNF-<italic>&#x003b1;</italic>, and IL-6 by levels; Western blot analyses for expression of iNOS and COX-2<break/><italic>In vivo:</italic> carrageenan-induced paw edema and thioglycollate-induced peritonitis</td><td align="center" rowspan="1" colspan="1">RAW 264.7 macrophages</td><td align="center" rowspan="1" colspan="1">Decreasing in the number of total cells and suppression of TNF-<italic>&#x003b1;</italic>, IL-1<italic>&#x003b2;</italic>, and IL-6 levels in peritoneal fluid<break/>Suppression of iNOS and COX-2 expression</td><td align="center" rowspan="1" colspan="1">Park et al. 2016 [<xref rid="B42" ref-type="bibr">42</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Essential oils from roots of <italic>Rhaponticum carthamoides</italic></td><td align="center" rowspan="1" colspan="1">25, 50, and 100&#x000a0;<italic>&#x003bc;</italic>g/mL</td><td align="center" rowspan="1" colspan="1">Measurement of cytokines IL-1<italic>&#x003b2;</italic>, IL-6, IL-8, IL-10, TNF-<italic>&#x003b1;</italic>, and GM-CSF and RT-PCR.<break/>ROS formation assay using H2DCF-DA.</td><td align="center" rowspan="1" colspan="1">Human astrocytes</td><td align="center" rowspan="1" colspan="1">Decreasing the expression of IL-1<italic>&#x003b2;</italic>, IL-6, and TNF-<italic>&#x003b1;</italic> and the ROS level</td><td align="center" rowspan="1" colspan="1">Skala et al. 2016 [<xref rid="B43" ref-type="bibr">43</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Essential oil from blossoms of <italic>Citrus aurantium</italic></td><td align="center" rowspan="1" colspan="1">15.625, 31.25, 62.5, 125, and 250&#x000a0;<italic>&#x003bc;</italic>g/mL</td><td align="center" rowspan="1" colspan="1">DPPH and ABTS radical scavenging activity<break/>Determination of morphology and NO production.<break/>Quantification of IL-6, TNF-<italic>&#x003b1;</italic>, and IL-1<italic>&#x003b2;</italic><break/>Reverse transcription and PCR-RT for iNOS</td><td align="center" rowspan="1" colspan="1">RAW 264.7 macrophages</td><td align="center" rowspan="1" colspan="1">Did not show scavenging effects on DPPH and ABTS radicals<break/>Inhibition of NO accumulation and suppression of IL-6, TNF-<italic>&#x003b1;</italic>, and IL-1<italic>&#x003b2;</italic> secretion<break/>Inhibition of the expression of COX-2 and NF-<italic>&#x003ba;</italic>B activation<break/>Involvement of the inflammation process through MAPK signaling pathways, by inhibiting phosphorylation of JNK (c-Jun N-terminal kinase) and p38</td><td align="center" rowspan="1" colspan="1">Shen et al. 2017 [<xref rid="B48" ref-type="bibr">48</xref>]</td></tr><tr><td align="center" colspan="6" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">l-Carveol, l-carvone, <italic>m</italic>-cymene, valencene, and guaiene</td><td align="center" rowspan="1" colspan="1">1, 10, and 100&#x000a0;<italic>&#x003bc;</italic>M</td><td align="center" rowspan="1" colspan="1">Protective effect against oxidative damage produced by superoxide anion production (O<sub>2</sub><sup>&#x000b7;&#x02212;)</sup> and hydrogen peroxide<break/>Determination of NO production<break/>Quantification of IL-1<italic>&#x003b1;</italic>, TNF-<italic>&#x003b1;</italic>, and IL-10<break/>Activity of NF-<italic>&#x003ba;</italic>B</td><td align="center" rowspan="1" colspan="1">RAW 264.7 macrophages</td><td align="center" rowspan="1" colspan="1">Reduction in TNF-<italic>&#x003b1;</italic> and IL-1<italic>&#x003b1;</italic> levels and increasing in the production of IL-10<break/>Guaiene and <italic>m</italic>-cymene inhibited NO production<break/>l-Carveol and <italic>m</italic>-cymene significantly inhibited O<sub>2</sub><sup>&#x000b7;&#x02212;</sup> production<break/>Terpenes suppressed NF-<italic>&#x003ba;</italic>B activity</td><td align="center" rowspan="1" colspan="1">Marques et al. 2018 [<xref rid="B52" ref-type="bibr">52</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>EO: essential oil; NO: nitric oxide; ROS: reactive oxygen species; iNOS: inducible nitric oxide synthase; IL-1<italic>&#x003b2;</italic>: interleukin-1 beta; DPPH: 2,2-diphenyl-1-picrylhydrazyl radical; LPS: lipopolysaccharide; M: male; ABTS: 2,2&#x02032;-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid); NF-<italic>&#x003ba;</italic>B: nuclear factor kappa B, COX-2: cyclooxygenase; TNF-<italic>&#x003b1;</italic>: tumor necrosis factor alpha; IL-6: interleukin-6; IL-8: interleukin-8; IL-10: interleukin-10; FRAP: ferric reducing antioxidant power; MPO: myeloperoxidase; PCR-RT: real-time quantitative polymerase chain reaction; H2DCF-DA: 2&#x02032;,7&#x02032;-dichlorodihydrofluorescein diacetate; 5-LOX: 5, lipoxygenase; PGE2: prostaglandin E2; MAPK: mitogen-activated protein kinases; GAPDH: glyceraldehyde 3-phosphate dehydrogenase.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tab3" content-type="sidewaystable" orientation="portrait" position="float"><label>Table 3</label><caption><p><italic>In vivo</italic> studies involving essential oils and antioxidant activity.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Essential oil and/or majority constituent</th><th align="center" rowspan="1" colspan="1">Animals (strain/sex), <italic>n</italic> (per group)</th><th align="center" rowspan="1" colspan="1">Doses, route, and administration period</th><th align="center" rowspan="1" colspan="1">Antioxidant assays</th><th align="center" rowspan="1" colspan="1">Experimental model of inflammation</th><th align="center" rowspan="1" colspan="1">General results</th><th align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Essential oil of ginger</td><td align="center" rowspan="1" colspan="1">Mice (Balb/c/), <italic>n</italic> = 3, 5, or 6</td><td align="center" rowspan="1" colspan="1">10, 50, 100, 250, 500, or 1000&#x02009;mg/kg (i.p. or p.o.), single dose or 4 days</td><td align="center" rowspan="1" colspan="1">Lipid peroxidation, SOD and hydroxyl activity assay<break/>DPPH and ABTS radical scavenging and FRAP assay<break/>PMA-induced radical generation and dosage of SOD, CAT, and GSH <italic>in vivo</italic></td><td align="center" rowspan="1" colspan="1">Formalin induced chronic inflammation</td><td align="center" rowspan="1" colspan="1">Scavenged superoxide, DPPH, hydroxyl radicals, and lipid peroxidation inhibition<break/>Increase in SOD, GSH, and GR enzyme levels in blood and glutathione peroxidase and SOD enzymes in liver<break/>Reduction in formalin-induced chronic inflammation</td><td align="center" rowspan="1" colspan="1">Jeena et al. 2013 [<xref rid="B26" ref-type="bibr">26</xref>]</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Anethole</td><td align="center" rowspan="1" colspan="1">Mice (Swiss/M), <italic>n</italic> = 6</td><td align="center" rowspan="1" colspan="1">125, 250, or 500&#x02009;mg/kg (p.o.), for until 7 days</td><td align="center" rowspan="1" colspan="1">MPO activity</td><td align="center" rowspan="1" colspan="1">Paw edema induced by complete Freund's adjuvant</td><td align="center" rowspan="1" colspan="1">Inhibition of paw edema on all of the days analyzed<break/>Inhibition of MPO activity and reduction of TNF-<italic>&#x003b1;</italic>, IL-1<italic>&#x003b2;</italic>, and IL-17 levels in acute and persistent inflammation models</td><td align="center" rowspan="1" colspan="1">Ritter et al. 2013 [<xref rid="B25" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Essential oil of <italic>Nigella sativa</italic> L.</td><td align="center" rowspan="1" colspan="1">Rats (Sprague&#x02013;Dawley), <italic>n</italic> = 7</td><td align="center" rowspan="1" colspan="1">500&#x02009;mg/kg (p.o.), 3 times a 1 day</td><td align="center" rowspan="1" colspan="1">Determination of SOD, CAT activity, and MDA and NO levels</td><td align="center" rowspan="1" colspan="1">LPS induced inflammation</td><td align="center" rowspan="1" colspan="1">Increase in SOD and CAT, and reduction of MDA and NO in lung</td><td align="center" rowspan="1" colspan="1">Entok et al. 2014 [<xref rid="B36" ref-type="bibr">36</xref>]</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Essential oil of <italic>Piper nigrum</italic> Linn</td><td align="center" rowspan="1" colspan="1">Mice (Balb/C), <italic>n</italic> = 5 or 6</td><td align="center" rowspan="1" colspan="1">10, 50, 100, 250, 500, or 1000&#x02009;mg/kg (i.p. or p.o.), 5 or 30 days.</td><td align="center" rowspan="1" colspan="1">Lipid peroxidation and SOD and hydroxyl activity assay<break/>DPPH radical scavenging and FRAP assay<break/>PMA-induced radical generation and dosage of SOD, CAT, and GSH <italic>in vivo</italic></td><td align="center" rowspan="1" colspan="1">Formalin induced chronic inflammation</td><td align="center" rowspan="1" colspan="1">Scavenged SOD, DPPH, and hydroxyl radicals; inhibition of lipid peroxidation <italic>in vitro</italic><break/>Increase in SOD and GSH enzyme levels in blood of mice and CAT, SOD, and GSH enzymes in liver<break/>Reduction of chronic inflammation in formalin test</td><td align="center" rowspan="1" colspan="1">Jeena et al., 2014 [<xref rid="B35" ref-type="bibr">35</xref>]</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Linalool</td><td align="center" rowspan="1" colspan="1">Mice (C57BL/6J/M), <italic>n</italic> = 10</td><td align="center" rowspan="1" colspan="1">5, 15 or 25&#x02009;mg/kg (s.c.)</td><td align="center" rowspan="1" colspan="1">ROS and SOD activity assay</td><td align="center" rowspan="1" colspan="1"><italic>Pasteurella multocida</italic> induced intranasal lung infection/inflammation</td><td align="center" rowspan="1" colspan="1">Increase in nuclear Nrf-2 protein amount and reduction in SOD expression<break/>Reduction in TNF-<italic>&#x003b1;</italic> and IL-6 levels and decrease in neutrophil accumulation</td><td align="center" rowspan="1" colspan="1">Wu et al. 2014 [<xref rid="B34" ref-type="bibr">34</xref>]</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Essential oil from blossoms of <italic>Citrus aurantium</italic> L.</td><td align="center" rowspan="1" colspan="1">Rats (Wistar/M), <italic>n</italic> = 8</td><td align="center" rowspan="1" colspan="1">5, 10, 20, 40, or 80&#x02009;mg/kg (i.p.) for until 7 days</td><td align="center" rowspan="1" colspan="1">Measurement of NO</td><td align="center" rowspan="1" colspan="1">Cotton pellet-induced granuloma</td><td align="center" rowspan="1" colspan="1">Decrease in transudate and granuloma formation amount involving the nitric oxide pathway</td><td align="center" rowspan="1" colspan="1">Khodabakhsh et al. 2014 [<xref rid="B33" ref-type="bibr">33</xref>]</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Essential oil of <italic>Camellia reticulata</italic> L.</td><td align="center" rowspan="1" colspan="1">Rats (Wistar/M), <italic>n</italic> = 6</td><td align="center" rowspan="1" colspan="1">200 or 400&#x02009;mg/kg (p.o.) for 11 days</td><td align="center" rowspan="1" colspan="1">Colonic GSH content and lipid peroxides concentration</td><td align="center" rowspan="1" colspan="1">Enterocolitis induced by indomethacin</td><td align="center" rowspan="1" colspan="1">Decrease in macroscopic and microscopic scores for inflammation<break/>Reduction in MPO and lipid peroxidation and increase in GSH content</td><td align="center" rowspan="1" colspan="1">Patil et al., 2014 [<xref rid="B32" ref-type="bibr">32</xref>]</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Essential oil of <italic>Pistacia integerrima</italic></td><td align="center" rowspan="1" colspan="1">Rats (Sprague-Dawley/F), <italic>n</italic> = 6</td><td align="center" rowspan="1" colspan="1">5-30&#x000a0;<italic>&#x003bc;</italic>g/mL; 10, 30, or 100&#x02009;mg/mL; and 7, 5, 15, or 30&#x02009;mg/kg (i.p.)</td><td align="center" rowspan="1" colspan="1">DPPH radical scavenging, lipoxygenase activity, and measurement of NO and MPO</td><td align="center" rowspan="1" colspan="1">LPS- and ovalbumin-induced bronchial inflammation</td><td align="center" rowspan="1" colspan="1">Inhibition of lipoxygenase enzyme and DPPH scavenging activity<break/>Antiallergic activity by inhibition of mast cell degranulation<break/>Reduction in total leucocyte, neutrophils, NO, total protein, and albumin levels in bronchoalveolar fluid and MPO levels in lung homogenates</td><td align="center" rowspan="1" colspan="1">Shirole et al. 2014 [<xref rid="B31" ref-type="bibr">31</xref>]</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Essential oil of thyme</td><td align="center" rowspan="1" colspan="1">Rats (Sprague-Dawley/M), <italic>n</italic> = 25</td><td align="center" rowspan="1" colspan="1">7, 5, 15, or 30&#x02009;mg/kg (i.p.) for 21 days</td><td align="center" rowspan="1" colspan="1">FRAP assay</td><td align="center" rowspan="1" colspan="1">Ulcer-forming induced by <italic>Shigella flexneri strain</italic></td><td align="center" rowspan="1" colspan="1">Synergistic activity of thyme oil decreased the inflammation of the lamina propria and decreased the bacterial load in the colon<break/>Increase in total antioxidant capacity time</td><td align="center" rowspan="1" colspan="1">Allam et al. 2015 [<xref rid="B40" ref-type="bibr">40</xref>]</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Essential oil from leaves of <italic>Choisya ternata</italic> Kunth</td><td align="center" rowspan="1" colspan="1">Mice (Webster/M), <italic>n</italic> = 4, 6, 8 or 10</td><td align="center" rowspan="1" colspan="1">3-10 or 30&#x02009;mg/kg (p.o.)</td><td align="center" rowspan="1" colspan="1">NO levels and trapping capacity of anthranilates</td><td align="center" rowspan="1" colspan="1">Formalin test and subcutaneous air pouch (SAP) model</td><td align="center" rowspan="1" colspan="1">Reduction in migration, exudate volume, and protein extravasation and reduced levels of NO, TNF-<italic>&#x003b1;</italic>, and IL-1<italic>&#x003b2;</italic></td><td align="center" rowspan="1" colspan="1">Lin et al. 2014 [<xref rid="B29" ref-type="bibr">29</xref>]</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Carvacrol</td><td align="center" rowspan="1" colspan="1">Rats (Sprague-Dawley/F), <italic>n</italic> = 6, 7, or 8</td><td align="center" rowspan="1" colspan="1">20, 40, or 80&#x02009;mg/kg (p.o.) for 6 days</td><td align="center" rowspan="1" colspan="1">MDA and NO levels</td><td align="center" rowspan="1" colspan="1">LPS-induced peritoneal inflammation</td><td align="center" rowspan="1" colspan="1">Decrease in levels of TNF-<italic>&#x003b1;</italic> and IL-6, MDA, NO levels, and arginase activity levels</td><td align="center" rowspan="1" colspan="1">Kara et al., 2015 [<xref rid="B39" ref-type="bibr">39</xref>]</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Cinnamaldehyde</td><td align="center" rowspan="1" colspan="1">Rats (Sprague-Dawley/M), <italic>n</italic> = 6</td><td align="center" rowspan="1" colspan="1">30, 60, or 90 (p.o.) 1x/day for 30 days</td><td align="center" rowspan="1" colspan="1">Determination of intracellular levels of ROS</td><td align="center" rowspan="1" colspan="1">LPS-induced cardiac dysfunction</td><td align="center" rowspan="1" colspan="1">Inhibition of cardiac dysfunction, inflammatory infiltration, and the levels of TNF-<italic>&#x003b1;</italic>, IL-1<italic>&#x003b2;</italic>, and IL-6 in LPS stimulated rats by blocking the TLR4, NOX4, MAPK, and autophagy signaling pathway</td><td align="center" rowspan="1" colspan="1">Zhao et al., 2016 [<xref rid="B44" ref-type="bibr">44</xref>]</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Thymol</td><td align="center" rowspan="1" colspan="1">Rabbits (M), <italic>n</italic> = 6</td><td align="center" rowspan="1" colspan="1">3 or 6&#x02009;mg/kg (p.o) for 8 weeks</td><td align="center" rowspan="1" colspan="1">DPPH and ABTS radical scavenging activity and measurement of MDA level in serum</td><td align="center" rowspan="1" colspan="1">Inflammatory process in aortic intimal thickening</td><td align="center" rowspan="1" colspan="1">High antioxidant activity in both tests<break/>Reduction in TC, TG, LDL-C, and MDA levels<break/>Reduction in VCAM-1 and MCP-1 levels and proinflammatory cytokines IL-1<italic>&#x003b2;</italic>, IL-6, and TNF-<italic>&#x003b1;</italic></td><td align="center" rowspan="1" colspan="1">Yu et al. 2016 [<xref rid="B45" ref-type="bibr">45</xref>]</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Eucalyptol</td><td align="center" rowspan="1" colspan="1">Mice (C57BL/6/M), <italic>n</italic> = 8</td><td align="center" rowspan="1" colspan="1">1, 3, and 10&#x02009;mg/mL via inhalation (15&#x02009;min/daily) for 5 days</td><td align="center" rowspan="1" colspan="1">NBT assay, SOD and CAT activity<break/>Measurement of GSH and TBARS levels</td><td align="center" rowspan="1" colspan="1">Cigarette smoke exposure</td><td align="center" rowspan="1" colspan="1">Reduction in IL-1<italic>&#x003b2;</italic>, IL-6, and TNF-<italic>&#x003b1;</italic> levels<break/>Decrease in NF-<italic>&#x003ba;</italic>B expression<break/>Reduction in ROS, SOD, CAT, MDA, and GSH levels<break/>Rare presence of leukocytes in alveolar septa</td><td align="center" rowspan="1" colspan="1">Kennedy-Feitosa et al., 2016 [<xref rid="B46" ref-type="bibr">46</xref>]</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Carvacrol</td><td align="center" rowspan="1" colspan="1">Mice (Swiss/F), <italic>n</italic> = 5 or 8</td><td align="center" rowspan="1" colspan="1">25, 75, or 150&#x02009;mg/kg (i.p.) for 8 days</td><td align="center" rowspan="1" colspan="1">GSH, MDA, and NO levels</td><td align="center" rowspan="1" colspan="1">Intestinal mucositis induced by CPT-11 chemotherapy</td><td align="center" rowspan="1" colspan="1">Reduction in TNF-<italic>&#x003b1;</italic>, IL-1<italic>&#x003b2;</italic>, and KC levels<break/>Decrease in MPO, NF-<italic>&#x003ba;</italic>B, COX-2, and oxidative stress (GSH, MDA, and NO levels)</td><td align="center" rowspan="1" colspan="1">Alvarenga et al. 2016 [<xref rid="B47" ref-type="bibr">47</xref>]</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>&#x003b2;</italic>-Elemene</td><td align="center" rowspan="1" colspan="1">Mice ApoE&#x02212;/&#x02212; (C57BL/6/M), <italic>n</italic> = 6</td><td align="center" rowspan="1" colspan="1">Not related</td><td align="center" rowspan="1" colspan="1">Measurement of eNOS and NO concentrations, ROS assay, enzyme activity SOD, CAT, GPx, GSH, and MDA</td><td align="center" rowspan="1" colspan="1">Atherosclerosis induced by high fat</td><td align="center" rowspan="1" colspan="1">Inhibition of atherosclerotic lesion size and increase in plaque stability<break/>Reduction of vascular oxidative stress and preventing proinflammatory cytokine production<break/>Improvement in NO levels, expression of eNOS, and phosphorylation of eNOSser1177 and Akt</td><td align="center" rowspan="1" colspan="1">Liu et al. 2017 [<xref rid="B49" ref-type="bibr">49</xref>]</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Carvacrol</td><td align="center" rowspan="1" colspan="1">Rat (Fischer 344/M), <italic>n</italic> = 6</td><td align="center" rowspan="1" colspan="1">50&#x02009;mg/kg (p.o.) for 7 days before and 7 days, after tumor induction</td><td align="center" rowspan="1" colspan="1">Antioxidant enzyme activities SOD, CAT, GPx, GR, GSH, vitamin E and vitamin C, and NO level and MDA contents</td><td align="center" rowspan="1" colspan="1">Colitis induced by DMH-associated colon cancer</td><td align="center" rowspan="1" colspan="1">Increase in SOD, CAT, and GSH levels and reduction in LPO, MPO, and NO<break/>Suppression of proinflammatory mediators iNOS and IL-1<italic>&#x003b2;</italic><break/>Reduction in ulcer size</td><td align="center" rowspan="1" colspan="1">Arigesavan and Sudhandiran 2017 [<xref rid="B51" ref-type="bibr">51</xref>]</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Essential oil of <italic>Zingiber cassumunar</italic> Roxb. in niosomes entrapped</td><td align="center" rowspan="1" colspan="1">Rats (Wistar/M), <italic>n</italic> = 5</td><td align="center" rowspan="1" colspan="1">12.5&#x02013;400&#x000a0;<italic>&#x003bc;</italic>g/mL</td><td align="center" rowspan="1" colspan="1">DPPH radical scavenging</td><td align="center" rowspan="1" colspan="1">LPS-induced subcutaneous inflammatory assay</td><td align="center" rowspan="1" colspan="1">Inhibition of DPPH radical and decrease in skin temperature and blood flow, reducing tissue inflammation process</td><td align="center" rowspan="1" colspan="1">Leelarungrayub et al. 2017 [<xref rid="B50" ref-type="bibr">50</xref>]</td></tr><tr><td align="center" colspan="7" rowspan="1"><hr/></td></tr><tr><td align="left" rowspan="1" colspan="1">Thymol in nanoparticles from natural lipids</td><td align="center" rowspan="1" colspan="1">Mice (C57B/6/M), <italic>n</italic> = 10 or 12</td><td align="center" rowspan="1" colspan="1">5&#x02009;mg/day (p.o.), 15 days</td><td align="center" rowspan="1" colspan="1">Anthralin-induced ear edema model</td><td align="center" rowspan="1" colspan="1">Imiquimod-induced psoriasis</td><td align="center" rowspan="1" colspan="1">Improved inflammation and healing, on anthralin model and imiquimod</td><td align="center" rowspan="1" colspan="1">Pivetta et al. 2018 [<xref rid="B53" ref-type="bibr">53</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>eNOS: nitric oxide synthase; NO: nitric oxide; ROS: reactive oxygen species; SOD: superoxide dismutase; CAT: catalase; GPx: glutathione peroxidase; GSH: glutathione; GR: reductase glutathione; MDA: malondialdehyde; DMH: 1,2-dimethyl hydrazine; LPO: lipid peroxides; iNOS: inducible nitric oxide synthase; IL-1<italic>&#x003b2;</italic>: interleukin-1 beta; DPPH: 2,2-diphenyl-1-picrylhydrazyl radical; LPS: lipopolysaccharide; M: male; ABTS: 2,2&#x02032;-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid); TC: total cholesterol; TG: triglycerides; LDL: low-density lipoprotein; VCAM-1: vascular cell adhesion molecule-1; MCP-1: monocyte chemotactic protein-1 (MCP-1); NBT: nitroblue tetrazolium; TBARS: thiobarbituric acid; NF-<italic>&#x003ba;</italic>B: nuclear factor kappa B; MDA: malondialdehyde; CPT-11: irinotecan, Camptosar, Camptothecin-11; COX-2: cyclooxygenase; TNF-<italic>&#x003b1;</italic>: tumor necrosis factor alpha; IL-6: interleukin-6; IL-17: interleukin-17; FRAP: ferric reducing antioxidant power; MPO: myeloperoxidase; TNBS: trinitrobenzenesulphonic acid; Nrf-2: nuclear factor erythroid 2&#x02013;related factor 2; PMA: phorbol-12-myristate-13-acetate.</p></fn></table-wrap-foot></table-wrap></floats-group></article>